agtx_10q.htm

0001477932-22-000229.txt : 20220113 0001477932-22-000229.hdr.sgml : 20220113 20220113130910 ACCESSION NUMBER: 0001477932-22-000229 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 31 CONFORMED PERIOD OF REPORT: 20211130 FILED AS OF DATE: 20220113 DATE AS OF CHANGE: 20220113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Agentix Corp. CENTRAL INDEX KEY: 0001603345 STANDARD INDUSTRIAL CLASSIFICATION: PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821] IRS NUMBER: 462876282 STATE OF INCORPORATION: NV FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-55383 FILM NUMBER: 22528533 BUSINESS ADDRESS: STREET 1: 32932 PACIFIC COAST HIGHWAY STREET 2: #14-254 CITY: DANA POINT STATE: CA ZIP: 92629 BUSINESS PHONE: 321-229-2014 MAIL ADDRESS: STREET 1: 32932 PACIFIC COAST HIGHWAY STREET 2: #14-254 CITY: DANA POINT STATE: CA ZIP: 92629 FORMER COMPANY: FORMER CONFORMED NAME: FairWind Energy Inc. DATE OF NAME CHANGE: 20140321 10-Q 1 agtx_10q.htm FORM 10-Q agtx_10q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(MARK ONE)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended November 30, 2021

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______ to ______

Commission File No. 000-55383

AGENTIX CORP.

(Exact name of registrant as specified in its charter)

Nevada		46-2876282
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification No.)

32932 Pacific Coast Highway, #14-254

Dana Point, California 92629

(Address of principal executive offices, zip code)

(949) 933-5411

(Registrant’s telephone number, including area code)

_____________________________________________________

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered

Indicate by check mark whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (check one):

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Exchange Act Rule 12b-2 of the Exchange Act): Yes ☐ No ☒

As of January 10, 2022, there were 35,074,605 shares of common stock, $0.001 par value per share, outstanding.

AGENTIX CORP.

QUARTERLY REPORT ON FORM 10-Q

FOR THE PERIOD ENDED NOVEMBER 30, 2021

INDEX

Index		Page

Part I. Financial Information

Item 1.	Financial Statements	F-1

	Consolidated Balance Sheets at November 30, 2021 (Unaudited) and August 31, 2021 (Audited).	F-1

	Unaudited Consolidated Statement of Operations for the three months ended November 30, 2021 and November 30, 2020.	F-2

	Unaudited Consolidated Statement of Changes in Stockholders’ (Deficit) Equity for the three months ended November 30, 2021 and 2020.	F-3

	Unaudited Consolidated Statement of Cash Flows for the three months ended November 30, 2021 and 2020.	F-4

	Notes to Financial Statements (Unaudited).	F-5

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	4

Item 3.	Quantitative and Qualitative Disclosures About Market Risk.	7

Item 4.	Controls and Procedures.	7

Part II. Other Information

Item 1.	Legal Proceedings.	8

Item 1A.	Risk Factors	8

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.	8

Item 3.	Defaults Upon Senior Securities.	8

Item 4.	Mine Safety Disclosures.	8

Item 5.	Other Information.	8

Item 6.	Exhibits.	9

Signatures		10

Table of Contents

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q of Agentix Corp., a Nevada corporation (the “Company”), contains “forward-looking statements,” as defined in the United States Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as “may”, “will”, “should”, “could”, “expects”, “plans”, “intends”, “anticipates”, “believes”, “estimates”, “predicts”, “potential” or “continue” or the negative of such terms and other comparable terminology. These forward-looking statements include, without limitation, statements about our market opportunity, our strategies, competition, expected activities and expenditures as we pursue our business plan, and the adequacy of our available cash resources. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Actual results may differ materially from the predictions discussed in these forward-looking statements. The economic environment within which we operate could materially affect our actual results. Additional factors that could materially affect these forward-looking statements and/or predictions include, among other things: the ongoing coronavirus pandemic, the Company’s need for and ability to obtain additional financing, product demand, market and customer acceptance, competition, pricing and development difficulties, as well as general industry and market conditions and growth rates, general economic conditions, and other factors over which we have little or no control; and other factors discussed in the Company’s filings with the Securities and Exchange Commission (“SEC”).

Our management has included projections and estimates in this Form 10-Q, which are based primarily on management’s experience in the industry, assessments of our results of operations, discussions and negotiations with third parties and a review of information filed by our competitors with the SEC or otherwise publicly available. We caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. We disclaim any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

Table of Contents

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS.

Agentix Corp. and Subsidiaries

Consolidated Balance Sheets

	November 30, 2021			August 31, 2021
	(Unaudited)			(Audited)
Assets
Current Assets
Cash	$	1,237		$	1,768
Inventory		49,439			49,439
Total current assets		50,676			51,207

Total assets	$	50,676		$	51,207

Liabilities and Stockholders’ (Deficit) Equity
Current Liabilities
Accounts payable	$	120,771		$	121,239
Accounts payable - related party		652,289			485,603
Accrued expenses		100			100
Total current liabilities		773,160			606,942

Long Term Liabilities		-			-
Total liabilities		773,160			606,942

Commitments and Contingencies		-			-

Stockholders’ Deficit
Common stock par value $0.001: 50,000,000 shares authorized;
35,074,605 and 34,874,605 shares issued and outstanding as of November 30, 2021 and August 31, 2021, respectively		35,075			34,875
Common stock to be issued (320,000 and 520,000 shares at November 30, 2021 and August 31, 2021, respectively)		80,000			180,000
Additional paid-in capital		1,033,448			933,648
Accumulated deficit		(1,871,007	)		(1,704,258	)
Total stockholders’ deficit		(722,484	)		(555,735	)
Total liabilities and stockholders’ deficit	$	50,676		$	51,207

See accompanying notes to the unaudited consolidated financial statements.

F-1

Table of Contents

Agentix Corp. and Subsidiaries

Unaudited Consolidated Statement of Operations

	Three Months Ended			Three Months Ended
	November 30, 2021			November 30, 2020

Operating Expenses
Professional fees	$	108,465		$	184,563
Research and development		42,950			15,488
General and administrative expenses		15,335			16,667

Total operating expenses		166,750			216,718

Loss from operations		(166,750	)		(216,718	)

Other (Income)
Interest income		-			(5	)

Loss before Income tax provision		(166,750	)		(216,713	)

Income tax provision		-			-

Net loss	$	(166,750	)	$	(216,713	)

Loss per share
- Basic and diluted	$	(0.00	)	$	(0.01	)

Weighted average common shares outstanding
- Basic and diluted		34,965,716			34,489,605

See accompanying notes to the unaudited consolidated financial statements.

F-2

Table of Contents

Agentix Corp. and Subsidiaries

Unaudited Consolidated Statement of Changes in Stockholders’ (Deficit) Equity

For the Three Months Ended November 30, 2021 and 2020

	Common stock par value $0.001				Common			Additional					Total Stockholders’
	Number of Shares		Amount		Stock to be Issued			Paid-in Capital		Accumulated Deficit			(Deficit) Equity

Balance, August 31, 2021		34,874,605	$	34,875	$	180,000		$	933,648	$	(1,704,258	)	$	(555,735	)

Issuance of previous common stock to be issue		200,000		200		(100,000	)		99,800		-			-

Net loss											(166,750	)		(166,750	)

Balance, November 30, 2021 (unaudited)		35,074,605	$	35,075	$	80,000		$	1,033,448	$	(1,871,007	)	$	(722,484	)

Balance, August 31, 2020		34,489,605	$	34,490	$	-		$	552,883	$	(363,911	)	$	223,462

Net Loss											(216,713	)		(216,713	)

Balance, November 30, 2020 (unaudited)		34,489,605		34,490		-			552,883		(580,624	)		6,749

See accompanying notes to the unaudited consolidated financial statements.

F-3

Table of Contents

Agentix Corp. and Subsidiaries

Unaudited Consolidated Statement of Cash Flows

	Three Months Ended			Three Months Ended
	November 30, 2021			November 30, 2020

Cash Flows from Operating Activities
Net loss	$	(166,750	)	$	(216,713	)
Adjustments to reconcile net loss to net cash used in operating activities:
Changes in operating assets and liabilities:
Accounts payable and accounts payable - related party		166,219			(14,949	)
Net Cash Used in Operating Activities		(531	)		(231,662	)

Cash Flows from Investing Activities		-			-

Cash Flows from Financing Activities		-			-
Net Change in Cash		(531	)		(231,662	)

Cash - beginning of reporting period		1,768			242,750

Cash - end of reporting period	$	1,237		$	11,088

See accompanying notes to the unaudited consolidated financial statements.

F-4

Table of Contents

Note 1 - Organization and Basis of Presentation

Description of the Company

FairWind Energy, Inc. (the “Company”, “Fairwind Energy”) was incorporated on April 18, 2013 under the laws of the State of Nevada. Effective June 17, 2019, the Company changed its name to Agentix Corp. The Company is focused on the development of synthetic agonists, inverse agonists and antagonists which modulate the endocannabinoid system (ECS). The ECS is a network of G-protein coupled receptors (GPCRs) that help regulate a variety of metabolic and neurotransmission functions.

Merger with GSL Healthcare, Inc.

On May 28, 2020, the Company, entered into a Share Exchange Agreement (the “Share Exchange Agreement”), by and among the Company, and GSL Healthcare, Inc., a Nevada corporation (“GSL Healthcare”), and the holders of common stock of GSL Healthcare, which consisted of two stockholders. The closing date occurred on June 1, 2020.

Under the terms and conditions of the Share Exchange Agreement, the Company offered and sold 27,932,271 shares of common stock of the Company in consideration for all of the issued and outstanding shares of common stock of GSL Healthcare. The effect of the issuance is that former GSL Healthcare shareholders hold approximately 88.0% of the then issued shares of common stock of the Company, and GSL Healthcare is a wholly-owned subsidiary of the Company.

The merger between the Company and GSL Healthcare was treated as a reverse capitalization for financial statement reporting purposes with GSL Healthcare deemed the accounting acquirer and the Company deemed the accounting acquiree. Accordingly, GSL Healthcare’ assets, liabilities and results of operations became the historical financial statements of the Company. Prior to the Share Exchange, 3,806,613 shares of the Company’s then outstanding common stock remained outstanding as part of this merger.

Merger with Applied Biopharma

In July 2021, the Company entered into and completed an Agreement and Plan of Merger (the “Merger Agreement”), by and among the Company, AB Merger LLC, a Nevada limited liability company and wholly-owned subsidiary of the Company (“AB Merger”), and Applied Biopharma, pursuant to which Applied BioPharma merged into AB Merger and the effect of which is that, upon and assuming consummation of the Merger Agreement, Applied Biopharma became a wholly-owned subsidiary of the Company.

The acquisition of Applied Biopharma was considered immaterial, as Applied Biopharma had minimal activity and had no assets or liabilities as of the date of merger. As such, the Company has included the activity of Applied Biopharma for the period following the completion of the Merger Agreement.

Going Concern

The Company’s unaudited consolidated financial statements have been prepared assuming that it will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.

As reflected in the unaudited consolidated financial statements, the Company had an accumulated deficit on November 30, 2021, a net loss, and net cash used in operating activities. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

The Company is attempting to commence operations and generate sufficient revenue; however, the Company’s cash position is not sufficient to support its daily operations. While the Company believes in the viability of its strategy to commence operations and generate sufficient revenue and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon its ability to further implement its business plan and generate sufficient revenue and its ability to raise additional funds by way of a public or private offering.

The unaudited consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

Principles of Consolidation

The unaudited consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, GSL Healthcare, Inc., AB Merger LLC, and Applied Biopharma, all 100% owned entities. Intercompany transactions and balances have been eliminated in consolidation.

F-5

Table of Contents

Note 2 - Significant and Critical Accounting Policies and Practices

Basis of Presentation

The accompanying unaudited consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), and with the rules and regulations of the United States Securities and Exchange Commission (“SEC”) to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited interim consolidated financial statements furnished reflect all adjustments (consisting of normal recurring accruals) which are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented. Unaudited interim results are not necessarily indicative of the results for the full fiscal year. These financial statements should be read in conjunction with the audited financial statements of the Company for the reporting period ended August 31, 2021 and notes thereto contained in the Company’s Annual Report on Form 10-K.

Fair Value of Financial Instruments

The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in generally accepted accounting principles (GAAP) and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:

Level 1	Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.

Level 2	Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.

Level 3	Pricing inputs that are generally unobservable inputs and not corroborated by market data.

Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.

The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.

The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts payable and accrued expenses approximate their fair values because of the short maturity of these instruments. The Company’s equity investments are considered Level 3, as pricing inputs are generally unobservable and not corroborated by market data.

Inventories

Inventories are stated at the lower of cost or market. Cost is determined principally on a first-in-first-out average cost basis. Inventories consist of finished goods held for sale. Management regularly reviews inventory quantities on-hand and records an inventory provision for excess or obsolete inventory based on the future expected demand for products. Inventory write-downs are measured as the difference between the cost of the inventory and market value, based upon assumptions about future demand that are inherently difficult to assess. During the three months ended November 30, 2021, the Company did not record a provision for excess or obsolete inventory.

Research and Development

The Company follows paragraph 730-10-25-1 of the FASB Accounting Standards Codification (formerly Statement of Financial Accounting Standards No. 2 ”Accounting for Research and Development Costs”) and paragraph 730-20-25-11 of the FASB Accounting Standards Codification (formerly Statement of Financial Accounting Standards No. 68 ”Research and Development Arrangements”) for research and development costs. Research and development costs are charged to expense as incurred. Research and development costs consist primarily of remuneration for material and testing costs for research and development.

Related Parties

The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions.

Pursuant to Section 850-10-20 the related parties include a. affiliates (“Affiliate” means, with respect to any specified Person, any other Person that, directly or indirectly through one or more intermediaries, controls, is controlled by or is under common control with such Person, as such terms are used in and construed under Rule 405 under the Securities Act) of the Company; b. entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c. trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d. principal owners of the Company; e. management of the Company; f. other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g. other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a. the nature of the relationship(s) involved; b. a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c. the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d. amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

Deferred Tax Assets and Income Tax Provision

The Company accounts for income taxes under Section 740-10-30 of the FASB Accounting Standards Codification. Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the statements of operations in the period that includes the enactment date.

The Company adopted section 740-10-25 of the FASB Accounting Standards Codification (“Section 740-10-25”). Section 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under Section 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Section 740-10-25 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures.

Earnings per Share

Earnings per share (“EPS”) are the amount of earnings attributable to each share of common stock. For convenience, the term is used to refer to either earnings or loss per share. EPS is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Pursuant to ASC Paragraphs 260-10-45-10 through 260-10-45-16, basic EPS shall be computed by dividing income available to common stockholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) during the period. Income available to common stockholders shall be computed by deducting both the dividends declared in the period on preferred stock (whether or not paid) and the dividends accumulated for the period on cumulative preferred stock (whether or not earned) from income from continuing operations (if that amount appears in the income statement) and also from net income. The computation of diluted EPS is similar to the computation of basic EPS except that the denominator is increased to include the number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued during the period to reflect the potential dilution that could occur from common shares issuable through contingent shares issuance arrangement, stock options or warrants.

Pursuant to ASC Paragraphs 260-10-45-45-21 through 260-10-45-45-23 Diluted EPS shall be based on the most advantageous conversion rate or exercise price from the standpoint of the security holder. The dilutive effect of outstanding call options and warrants (and their equivalents) issued by the reporting entity shall be reflected in diluted EPS by application of the treasury stock method unless the provisions of paragraphs 260-10-45-35 through 45-36 and 260-10-55-8 through 55-11 require that another method be applied. Equivalents of options and warrants include non-vested stock granted to employees, stock purchase contracts, and partially paid stock subscriptions (see paragraph 260–10–55–23). Anti-dilutive contracts, such as purchased put options and purchased call options, shall be excluded from diluted EPS. Under the treasury stock method: a. Exercise of options and warrants shall be assumed at the beginning of the period (or at time of issuance, if later) and common shares shall be assumed to be issued. b. The proceeds from exercise shall be assumed to be used to purchase common stock at the average market price during the period. (See paragraphs 260-10-45-29 and 260-10-55-4 through 55-5.) c. The incremental shares (the difference between the number of shares assumed issued and the number of shares assumed purchased) shall be included in the denominator of the diluted EPS computation.

There were no dilutive common shares for the three months ended November 30, 2021.

Stock-Based Payments

Stock-based compensation is accounted for based on the requirements of the Share-Based Payment Topic of ASC 718, “Compensation — Stock Compensation” (“ASC 718”), which requires recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). ASC 718 also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award.

For non-employees, the Company follows ASU No. 2018-07, Compensation - Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. Under the ASU No. 2017-07, most of the guidance on stock payments to nonemployees is aligned with the requirements for share-based payments granted to employees. As such, most of the guidance in ASC 718 associated with employee share-based payments, including most requirements related to classification and measurement, applies to nonemployee share-based payment arrangements.

No stock options or warrants were issued or outstanding as of November 30, 2021.

Recent Accounting Pronouncements

In December 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes,” which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. ASU 2019-12 was effective for the Company beginning in fiscal 2022. Adoption of ASU 2019-12 did not have an impact on the Company’s financial statements.

On August 5, 2020 the FASB issued the ASU 2020-06 “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging— Contracts in Entity’s Own Equity (Subtopic 815-40)”. The amendments in this update address issues identified as a result of the complexity associated with applying generally accepted accounting principles for certain financial instruments with characteristics of liabilities and equity. For convertible instruments, accounting models for specific features are removed and amendments to the disclosure requirements are included. For contracts in an entity’s own equity, simplifies the settlement assessment by removing some requirements. Additionally, the amendments in this update affect the diluted EPS calculation for instruments that may be settled in cash or shares and for convertible instruments. The amendments in this update are effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. The Company is assessing the effects, if any, that the adoption of this accounting pronouncement may have on its financial statements.

Note 3 – Related Parties

During the three months ended November 30, 2021, the Company incurred $37,500 of management fees, $15,000 for reimbursement of rent and $15,187 of advances to the Company to cover certain operating expenses and accounts payable from SBS Management, a company controlled by Mr. Scott Stevens who is a shareholder of the Company. As of November 30, 2021, $191,420 was included in Accounts payable – related party on the accompanying unaudited balance sheet. During the three months ended November 30, 2020, the Company incurred $5,000 for reimbursement of rent and $1,003 of advances to the Company to cover certain operating expenses and accounts payable from SBS Management. As of August 31, 2021, $127,233 was owed to SBS Management and was included in Accounts payable – related party on the accompanying unaudited balance sheet. The advances are unsecured, non-interest bearing, with no formal terms of repayment.

During the three months ended November 30, 2021, Gray’s Peak Capital, a company founded by Mr. Scott Stevens who is a shareholder of the Company, made advances to the Company to cover certain operating expenses. These advances are unsecured, non-interest bearing, with no formal terms of repayment. As of November 30, 2021 and August 31, 2021, the amounts due Gray’s Peak Capital for these advances was $155,370 and $120,870, respectively, and was included in accounts payable – related party on the accompanying balance sheet.

During the three months ended November 30, 2021 the Company incurred $18,000 of consulting fees from a shareholder of the company of which $122,500 and $107,500 was included in accounts payable – related party on the accompanying balance sheet as of November 30, 2021 and August 31, 2021, respectively.

During the three months ended November 30, 2021, the Company incurred $45,000 from a consulting and employment agreement with its CEO of which $175,000 and $130,000 was included in accounts payable – related party on the accompanying balance sheet as of November 30, 2021 and August 31, 2021, respectively.

Note 4 – Equity

As of November 30, 2021 and August 31, 2021, the Company has authorized 50,000,000 shares of common stock at a par value of $0.001 per share and had issued and outstanding shares of common stock of 35,074,605 and 34,874,605, respectively.

Shares issued

During the three months ended November 30, 2021, the Company issued 200,000 shares of its common stock sold at a price of $0.50 per share which was previously sold and reflected as common stock to be issued as of August 31, 2021.

As of November 30, 2021 and August 31, 2021, the Company had not issued 320,000 and 520,000, respectively, of shares previously sold and as such, $80,000 and $180,000, respectively, was reflected in the accompanying consolidated balance sheet as common stock to be issued.

Note 5 – Subsequent Events

In accordance with ASC 855, the Company has analyzed its operations subsequent to November 30, 2021 through the date these financial statements were issued and has determined that it does not have any material subsequent events to disclose in these financial statements.

F-9

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

The following information should be read in conjunction with (i) the financial statements of Agentix Corp., a Nevada corporation (the “Company”), and development stage company, and the notes thereto appearing elsewhere in this Form 10-Q together with (ii) the more detailed business information and the August 31, 2021 audited financial statements and related notes included in the Company’s Form 10-K (File No. 000-55383; the “Form 10-K”), as filed with the Securities and Exchange Commission on October 7, 2021. Statements in this section and elsewhere in this Form 10-Q that are not statements of historical or current fact constitute “forward-looking” statements.

Merger with GSL Healthcare

On May 28, 2020, we entered into a Share Exchange Agreement (the “Share Exchange Agreement”), by and among the Company, and GSL Healthcare, Inc., a Nevada corporation (“GSL Healthcare”), and the holders of common stock of GSL Healthcare, which consisted of two stockholders. The closing date occurred on June 1, 2020.

Under the terms and conditions of the Share Exchange Agreement, we offered and sold 27,932,271 shares of our common stock of the Company in consideration for all of the issued and outstanding shares of common stock of GSL Healthcare. The effect of the issuance is that former two GSL Healthcare shareholders hold approximately 88.0% of the then issued shares of common stock of the Company, and GSL Healthcare is now a wholly-owned subsidiary of the Company.

The merger between the Company and GSL Healthcare was treated as a reverse capitalization for financial statement reporting purposes with GSL Healthcare deemed the accounting acquirer and the Company deemed the accounting acquiree. Accordingly, GSL Healthcare’ assets, liabilities and results of operations became our historical financial statements. Prior to the Share Exchange, we had 3,806,613 shares of outstanding common stock which remained outstanding as part of the merger.

Merger with Applied Biopharma

In July 2021, we entered into and completed an Agreement and Plan of Merger (the “Merger Agreement”), by and among our Company, AB Merger LLC, a Nevada limited liability company and our wholly-owned subsidiary (“AB Merger”), and Applied Biopharma, pursuant to which Applied BioPharma merged into AB Merger and the effect of which is that, upon and assuming consummation of the Merger Agreement, Applied Biopharma became a wholly-owned subsidiary of our Company.

We paid one share of our common stock for the acquisition of Applied Biopharma under the terms and conditions of the Merger Agreement. The acquisition of Applied Biopharma was considered immaterial, as Applied Biopharma had minimal activity and had no assets or liabilities as of the date of acquisition. As such, we have included the activity of Applied Biopharma for the period following the completion of the Merger Agreement.

COVID-19

We continue to evaluate the impact of the COVID-19 pandemic on the industry and our Company and have concluded that while it is reasonably possible that the virus could have a negative effect on our financial position and results of our operations, the specific impact is not readily determinable as of the date of this filing. Our financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Table of Contents

CRITICAL ACCOUNTING POLICIES

The discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”). The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. We have identified the policies below as critical to our business operations and to the understanding of our financial results:

Basis of Accounting

Our financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), and with the rules and regulations of the SEC to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited interim financial statements furnished reflect all adjustments (consisting of normal recurring accruals) which are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented. Unaudited interim results are not necessarily indicative of the results for the full fiscal year. These financial statements should be read in conjunction with our audited financial statements for the reporting period ended August 31, 2021, as filed on October 7, 2021, and notes thereto contained in our Annual Report on Form 10-K.

Deferred Tax Assets and Income Tax Provision

We account for income taxes under Section 740-10-30 of the FASB Accounting Standards Codification. Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent we conclude it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the statements of operations in the period that includes the enactment date.

We adopted section 740-10-25 of the FASB Accounting Standards Codification (“Section 740-10-25”). Section 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under Section 740-10-25, we may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Section 740-10-25 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures.

Recent Accounting Pronouncements

We do not expect the adoption of recently issued accounting pronouncements to have a significant impact on its results of operations, financial position or cash flow.

Table of Contents

RESULTS OF OPERATIONS

Three Months Ended November 30, 2021 as compared to Three Months Ended November 30, 2020:

We recorded no revenues during the three months ended November 30, 2021 and 2020.

For the three months ended November 30, 2021, we incurred total professional fees of $108,465 as compared to $184,563 for the three months ended November 30, 2020. The decrease of $76,098 related to less professional fees received.

For the three months ended November 30, 2021, we incurred total research and development expenses of $42,950 as compared to $15,488 for the three months ended November 30, 2020. The increase of $27,462 related to our development efforts.

For the three months ended November 30, 2021, general and administrative expenses were essentially flat from the same comparable period in 2020 as general and administrative expenses decreased $1,332.

For the three months ended November 30, 2021, we used $531 of cash in our operations as compared to $231,662 during the comparable period in 2020. The decrease in cash used in our operations related primarily to obtaining funding from our related parties to pay operating expenses as compared to prior year as we had a higher cash balance in our prior year that was available to pay operating costs. We did not incur or obtain cash from investing or financing activities during the three months ended November 30, 2021 and 2020, respectively.

Liquidity and Capital Resources

Our unaudited consolidated financial statements have been prepared assuming that we will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business. As reflected in our unaudited consolidated financial statements, we had an accumulated deficit on November 30, 2021, we did not incur any revenue and we incurred a net loss along with a net use of cash in our operating activities during the three months ended November 30, 2021. These factors raise substantial doubt about our ability to continue as a going concern.

We are attempting to commence operations and generate sufficient revenue; however, our cash position is not sufficient to support our daily operations. As such, we will need to raise funds to complete our plan of operation and fund our ongoing operational expenses for the next 12 months. Additional funding will likely come from equity financing from the sale of our common stock or debt financing. If we are successful in completing an equity financing, existing shareholders will experience dilution of their interest in our Company and if we obtain debt financing, the terms of any such debt financing may not be favorable to existing shareholders. We cannot provide investors with any assurance that we will be able to raise sufficient funding from the sale of our common stock or obtaining debt to fund our development activities and ongoing operational expenses. In the absence of such financing, our business will likely fail. There are no assurances that we will be able to achieve further sales of our common stock or any other form of additional financing. If we are unable to achieve the financing necessary to continue our plan of operations, then we will not be able to continue our development to complete our plan of operation and our business will fail.

Off-Balance Sheet Arrangements

The Company has no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on the financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to stockholders

Subsequent Events

In accordance with ASC 855, we have analyzed our operations subsequent to November 30, 2021 through the date these financial statements were issued, and have determined that we don’t have any other material subsequent events to disclose in these financial statements.

Table of Contents

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

As a smaller reporting company (as defined in Rule 12b-2 of the Exchange Act), we are not required to provide the information called for by this Item 3.

ITEM 4. CONTROLS AND PROCEDURES.

DISCLOSURE CONTROLS AND PROCEDURES

Under the supervision and with the participation of our management, our President and Chief Executive Officer, who acts as both our principal executive officer and our principal financial officer, are responsible for conducting an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as of the end of the fiscal year covered by this report. Disclosure controls and procedures means that the material information required to be included in our Securities and Exchange Commission reports is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms relating to our company, including any consolidating subsidiaries, and was made known to us by others within those entities, particularly during the period when this report was being prepared. Based on this evaluation, our principal executive officer and principal financial officer concluded as of the evaluation date that our disclosure controls and procedures were not effective as of November 30, 2021.

There were no changes in the Company’s internal controls over financial reporting during the most recently completed fiscal quarter that have materially affected or are reasonably likely to materially affect the Company’s internal control over financial reporting.

Table of Contents

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

The Company is not currently subject to any legal proceedings. From time to time, the Company may become subject to litigation or proceedings in connection with its business, as either a plaintiff or defendant. There are no such pending legal proceedings to which the Company is a party that, in the opinion of management, is likely to have a material adverse effect on the Company’s business, financial condition or results of operations.

ITEM 1A. RISK FACTORS

As a smaller reporting company (as defined in Rule 12b-2 of the Exchange Act), we are not required to provide the information called for by this Item 1A.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. MINE SAFETY DISCLOSURES.

None.

ITEM 5. OTHER INFORMATION.

None.

Table of Contents

ITEM 6. EXHIBITS.

(a) Exhibits required by Item 601 of Regulation SK.:

Number		Description

3.1.1*		Articles of Incorporation
3.1.2*		Certificate of Amendment to Articles of Incorporation
3.1.3*		Certificate of Change
3.2*		Bylaws
31.1*		Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*		Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*		Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS *		Inline XBRL Instance Document
101.SCH *		Inline XBRL Taxonomy Extension Schema Document
101.CAL *		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF *		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB *		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE *		XBRL Taxonomy Extension Presentation Linkbase Document

_____________

*Filed herewith.

† Inline XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	AGENTIX CORP.
	(Name of Registrant)

Date: January 13, 2022	By:	/s/ Rudy Mazzocchi
		Name: Rudy Mazzocchi
		Title: President and Chief Executive Officer (principal executive officer, principal accounting officer and principal financial officer)

EX-31.1 2 agtx_ex311.htm CERTIFICATION agtx_ex311.htm

EXHIBIT 31.1

SECTION 302 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER OF AGENTIX CORP.

I, Rudy Mazzocchi, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Agentix Corp.;

2.	Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3.	Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

	(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

	(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: January 13, 2022

By:

/s/ Rudy Mazzocchi

Rudy Mazzocchi

President and Chief Executive Officer

(principal executive officer, principal accounting officer and principal financial officer)

EX-31.2 3 agtx_ex312.htm CERTIFICATION agtx_ex312.htm

EXHIBIT 31.2

SECTION 302 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF AGENTIX CORP.

I, Rudy Mazzocchi, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Agentix Corp.;

2.	Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3.	Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

	(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

	(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: January 13, 2022

By:

/s/ Rudy Mazzocchi

Rudy Mazzocchi

Secretary and Treasurer

(principal executive officer, principal accounting officer and principal financial officer)

EX-32.1 4 agtx_ex321.htm CERTIFICATION agtx_ex321.htm

EXHIBIT 32.1

SECTION 906 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND

PRINCIPAL FINANCIAL OFFICER OF AGENTIX CORP.

In connection with the accompanying Quarterly Report on Form 10-Q of Agentix Corp. for the quarter ended November 30, 2021, the undersigned, Rudy Mazzocchi, President and Chief Executive Officer of Agentix Corp., does hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	such Quarterly Report on Form 10-Q for the quarter ended November 30, 2021 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)	the information contained in such Quarterly Report on Form 10-Q for the quarter ended November 30, 2021 fairly presents, in all material respects, the financial condition and results of operations of Agentix Corp.

Date: January 13, 2022

By:

/s/ Rudy Mazzocchi

President and Chief Executive Officer

(principal executive officer, principal accounting officer

and principal financial officer)

EX-101.SCH 5 agtx-20211130.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 000004 - Statement - Unaudited Consolidated Statement of Operations link:presentationLink link:calculationLink link:definitionLink 000005 - Statement - Unaudited Consolidated Statement of Changes in Stockholders (Deficit) Equity link:presentationLink link:calculationLink link:definitionLink 000006 - Statement - Unaudited Consolidated Statement of Cash Flows link:presentationLink link:calculationLink link:definitionLink 000007 - Disclosure - Organization and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 000008 - Disclosure - Significant and Critical Accounting Policies and Practices link:presentationLink link:calculationLink link:definitionLink 000009 - Disclosure - Related Parties link:presentationLink link:calculationLink link:definitionLink 000010 - Disclosure - Equity link:presentationLink link:calculationLink link:definitionLink 000011 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 000012 - Disclosure - Significant and Critical Accounting Policies and Practices (Policies) link:presentationLink link:calculationLink link:definitionLink 000013 - Disclosure - Organization and Basis of Presentation (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000014 - Disclosure - Related Parties (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000015 - Disclosure - Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 6 agtx-20211130_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Current Fiscal Year End Date Entity Small Business Entity Shell Company Entity Emerging Growth Company Entity Current Reporting Status Document Period End Date Entity Filer Category Document Fiscal Period Focus Document Fiscal Year Focus Entity Ex Transition Period Entity Common Stock Shares Outstanding Document Quarterly Report Document Transition Report Entity File Number Entity Incorporation State Country Code Entity Tax Identification Number Entity Address Address Line 1 Entity Address Address Line 2 Entity Address City Or Town Entity Address State Or Province Entity Address Postal Zip Code City Area Code Local Phone Number Entity Interactive Data Current Consolidated Balance Sheets Assets Current Assets Cash Inventory Total current assets [Assets, Current] Total assets [Assets] Liabilities and Stockholders' (Deficit) Equity Current Liabilities Accounts payable Accounts payable - related party Accrued expenses Total current liabilities [Liabilities, Current] Long Term Liabilities Total liabilities [Liabilities] Commitments and Contingencies Stockholders' Deficit Common stock par value $0.001: 50,000,000 shares authorized; 35,074,605 and 34,874,605 shares issued and outstanding as of November 30, 2021 and August 31, 2021, respectively Common stock to be issued (320,000 and 520,000 shares at November 30, 2021 and August 31, 2021, respectively) Additional paid-in capital Accumulated deficit Total stockholders' deficit [Stockholders' Equity Attributable to Parent] Total liabilities and stockholders' deficit [Liabilities and Equity] Common stock to be issued Stockholders' Deficit Common stock, shares par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Unaudited Consolidated Statement of Operations Operating Expenses Professional fees Research and development General and administrative expenses Total operating expenses [Operating Expenses] Loss from operations [Operating Income (Loss)] Other (Income) Interest income Loss before Income tax provision [Income (Loss) from Continuing Operations before Income Taxes, Domestic] Income tax provision Net loss [Net Income (Loss) Attributable to Parent] Loss per share - Basic and diluted Weighted average common shares outstanding Weighted average common shares outstanding- Basic and diluted Unaudited Consolidated Statement of Changes in Stockholders (Deficit) Equity Statement [Table] Statement [Line Items] Equity Components [Axis] Common stock par value $0.001 [Member] Common Stock To Be Issued [Member] Additional Paid-in Capital [Member] Accumulated Deficit [Member] Balance, shares [Shares, Issued] Balance, amount Net Loss Issuance of previous common stock to be issue, shares Issuance of previous common stock to be issue, amount Balance, shares Balance, amount Unaudited Consolidated Statement of Cash Flows Cash Flows from Operating Activities Net loss Adjustments to reconcile net loss to net cash used in operating activities: Changes in operating assets and liabilities: Accounts payable and accounts payable - related party Net Cash Used in Operating Activities Cash Flows from Investing Activities Cash Flows from Financing Activities Net Change in Cash Cash - beginning of reporting period Cash - end of reporting period Organization and Basis of Presentation Note 1 - Organization and Basis of Presentation Significant and Critical Accounting Policies and Practices Note 2 - Significant and Critical Accounting Policies and Practices Related Parties Note 3 - Related Parties Equity Note 4 - Equity Subsequent Events Note 5 - Subsequent Events Basis of Presentation Fair Value of Financial Instruments Inventories Research and Developments Related Parties Compensation Related Costs, Policy [Policy Text Block] Deferred Tax Assets and Income Tax Provision Earnings per Share Stock-Based Payments Recent Accounting Pronouncements Consolidated Entities [Axis] GSL Healthcare [Member] Common Stock Sold Percentage of Shares issued Owned entity Percentage Outstanding common stock Related Parties (Details Narrative) Related Party [Axis] Related Party Transaction [Axis] S B S Management [Member] Shareholder [Member] CEO [Member] Grays Peak [Member] Accounts payable - other related party Rent expense Management fees Advances Consulting fees Common stock, shares par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Common stock share issued for service, shares Shares reserved for future issuance, amount Common stock to be issued Share price The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Amount of interest income earned from interest bearing assets classified as other. Stated value of common units of ownership issued by a limited liability company (LLC). EX-101.CAL 7 agtx-20211130_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 8 agtx-20211130_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 9 agtx-20211130_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE XML 10 R1.htm IDEA: XBRL DOCUMENT

Cover - shares	3 Months Ended
Cover - shares	Nov. 30, 2021	Jan. 10, 2022
Cover [Abstract]
Entity Registrant Name	AGENTIX CORP.
Entity Central Index Key	0001603345
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--08-31
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	true
Entity Current Reporting Status	Yes
Document Period End Date	Nov. 30, 2021
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2022
Entity Ex Transition Period	false
Entity Common Stock Shares Outstanding		35,074,605
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-55383
Entity Incorporation State Country Code	NV
Entity Tax Identification Number	46-2876282
Entity Address Address Line 1	32932 Pacific Coast Highway
Entity Address Address Line 2	#14-254
Entity Address City Or Town	Dana Point
Entity Address State Or Province	CA
Entity Address Postal Zip Code	92629
City Area Code	949
Local Phone Number	933-5411
Entity Interactive Data Current	Yes

XML 11 R2.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets - USD ($)	Nov. 30, 2021	Aug. 31, 2021
Current Assets
Cash	$ 1,237	$ 1,768
Inventory	49,439	49,439
Total current assets	50,676	51,207
Total assets	50,676	51,207
Current Liabilities
Accounts payable	120,771	121,239
Accounts payable - related party	652,289	485,603
Accrued expenses	100	100
Total current liabilities	773,160	606,942
Long Term Liabilities	0	0
Total liabilities	773,160	606,942
Commitments and Contingencies	0	0
Stockholders' Deficit
Common stock par value $0.001: 50,000,000 shares authorized; 35,074,605 and 34,874,605 shares issued and outstanding as of November 30, 2021 and August 31, 2021, respectively	35,075	34,875
Common stock to be issued (320,000 and 520,000 shares at November 30, 2021 and August 31, 2021, respectively)	80,000	180,000
Additional paid-in capital	1,033,448	933,648
Accumulated deficit	(1,871,007)	(1,704,258)
Total stockholders' deficit	(722,484)	(555,735)
Total liabilities and stockholders' deficit	$ 50,676	$ 51,207

XML 12 R3.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets (Parenthetical) - $ / shares	Nov. 30, 2021	Aug. 31, 2021
Consolidated Balance Sheets
Common stock to be issued	320,000	520,000
Stockholders' Deficit
Common stock, shares par value	$ 0.001	$ 0.001
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	35,074,605	34,874,605
Common stock, shares outstanding	35,074,605	34,874,605

XML 13 R4.htm IDEA: XBRL DOCUMENT

Unaudited Consolidated Statement of Operations - USD ($)	3 Months Ended
	Nov. 30, 2021	Nov. 30, 2020
Operating Expenses
Professional fees	$ 108,465	$ 184,563
Research and development	42,950	15,488
General and administrative expenses	15,335	16,667
Total operating expenses	166,750	216,718
Loss from operations	(166,750)	(216,718)
Other (Income)
Interest income	0	(5)
Loss before Income tax provision	(166,750)	(216,713)
Income tax provision	0	0
Net loss	$ (166,750)	$ (216,713)
Loss per share
- Basic and diluted	$ (0.00)	$ (0.01)
Weighted average common shares outstanding
Weighted average common shares outstanding- Basic and diluted	34,965,716	34,489,605

XML 14 R5.htm IDEA: XBRL DOCUMENT

Unaudited Consolidated Statement of Changes in Stockholders (Deficit) Equity - USD ($)	Total	Common stock par value $0.001 [Member]	Common Stock To Be Issued [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]
Balance, shares at Aug. 31, 2020		34,489,605
Balance, amount at Aug. 31, 2020	$ 223,462	$ 34,490	$ 0	$ 552,883	$ (363,911)
Net Loss	(216,713)				(216,713)
Balance, shares at Nov. 30, 2020		34,489,605
Balance, amount at Nov. 30, 2020	6,749	$ 34,490	0	552,883	(580,624)
Balance, shares at Aug. 31, 2021		34,874,605
Balance, amount at Aug. 31, 2021	(555,735)	$ 34,875	180,000	933,648	(1,704,258)
Net Loss	(166,750)				(166,750)
Issuance of previous common stock to be issue, shares		200,000
Issuance of previous common stock to be issue, amount	0	$ 200	(100,000)	99,800	0
Balance, shares at Nov. 30, 2021		35,074,605
Balance, amount at Nov. 30, 2021	$ (722,484)	$ 35,075	$ 80,000	$ 1,033,448	$ (1,871,007)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794

+ Details

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References + Details

XML 15 R6.htm IDEA: XBRL DOCUMENT

Unaudited Consolidated Statement of Cash Flows - USD ($)	3 Months Ended
	Nov. 30, 2021	Nov. 30, 2020
Cash Flows from Operating Activities
Net loss	$ (166,750)	$ (216,713)
Changes in operating assets and liabilities:
Accounts payable and accounts payable - related party	166,219	(14,949)
Net Cash Used in Operating Activities	(531)	(231,662)
Cash Flows from Investing Activities	0	0
Cash Flows from Financing Activities	0	0
Net Change in Cash	(531)	(231,662)
Cash - beginning of reporting period	1,768	242,750
Cash - end of reporting period	$ 1,237	$ 11,088

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

XML 16 R7.htm IDEA: XBRL DOCUMENT

Organization and Basis of Presentation

3 Months Ended

Nov. 30, 2021

Organization and Basis of Presentation

Note 1 - Organization and Basis of Presentation

Note 1 - Organization and Basis of Presentation

Description of the Company

Merger with GSL Healthcare, Inc.

Merger with Applied Biopharma

Going Concern

Principles of Consolidation

XML 17 R8.htm IDEA: XBRL DOCUMENT

Significant and Critical Accounting Policies and Practices

3 Months Ended

Nov. 30, 2021

Significant and Critical Accounting Policies and Practices

Note 2 - Significant and Critical Accounting Policies and Practices

Note 2 - Significant and Critical Accounting Policies and Practices

Basis of Presentation

Fair Value of Financial Instruments

Level 1	Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.

Level 2	Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.

Level 3	Pricing inputs that are generally unobservable inputs and not corroborated by market data.

Inventories

Research and Development

Related Parties

The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions.

Deferred Tax Assets and Income Tax Provision

Earnings per Share

There were no dilutive common shares for the three months ended November 30, 2021.

Stock-Based Payments

No stock options or warrants were issued or outstanding as of November 30, 2021.

Recent Accounting Pronouncements

XML 18 R9.htm IDEA: XBRL DOCUMENT

Related Parties

3 Months Ended

Nov. 30, 2021

Related Parties

Note 3 - Related Parties

Note 3 – Related Parties

XML 19 R10.htm IDEA: XBRL DOCUMENT

Equity

3 Months Ended

Nov. 30, 2021

Equity

Note 4 - Equity

Note 4 – Equity

Shares issued

XML 20 R11.htm IDEA: XBRL DOCUMENT

Subsequent Events

3 Months Ended

Nov. 30, 2021

Subsequent Events

Note 5 - Subsequent Events

Note 5 – Subsequent Events

XML 21 R12.htm IDEA: XBRL DOCUMENT

Significant and Critical Accounting Policies and Practices (Policies)

3 Months Ended

Nov. 30, 2021

Significant and Critical Accounting Policies and Practices

Basis of Presentation

Fair Value of Financial Instruments

Level 1	Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.

Level 2	Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.

Level 3	Pricing inputs that are generally unobservable inputs and not corroborated by market data.

Inventories

Research and Developments

Related Parties

The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions.

Deferred Tax Assets and Income Tax Provision

Earnings per Share

There were no dilutive common shares for the three months ended November 30, 2021.

Stock-Based Payments

No stock options or warrants were issued or outstanding as of November 30, 2021.

Recent Accounting Pronouncements

XML 22 R13.htm IDEA: XBRL DOCUMENT

Organization and Basis of Presentation (Details Narrative) - shares	3 Months Ended
	Nov. 30, 2021	Aug. 31, 2021
Outstanding common stock	35,074,605	34,874,605
GSL Healthcare [Member]
Common Stock Sold	27,932,271
Percentage of Shares issued	88.00%
Owned entity Percentage	100.00%
Outstanding common stock	3,806,613

XML 23 R14.htm IDEA: XBRL DOCUMENT

Related Parties (Details Narrative) - USD ($)	3 Months Ended
Related Parties (Details Narrative) - USD ($)	Nov. 30, 2021	Nov. 30, 2020	Aug. 31, 2021
Consulting fees	$ 108,465	$ 184,563
Shareholder [Member]
Accounts payable - other related party	122,500		$ 107,500
Consulting fees	18,000
S B S Management [Member]
Accounts payable - other related party	191,420		127,233
Rent expense	15,000	5,000
Management fees	37,500
Advances	15,187	$ 1,003
CEO [Member]
Accounts payable - other related party	175,000		130,000
Consulting fees	45,000
Grays Peak [Member]
Accounts payable - other related party	$ 155,370		$ 120,870

XML 24 R15.htm IDEA: XBRL DOCUMENT

Equity (Details Narrative) - USD ($)	3 Months Ended
Equity (Details Narrative) - USD ($)	Nov. 30, 2021	Aug. 31, 2021
Equity
Common stock, shares par value	$ 0.001	$ 0.001
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	35,074,605	34,874,605
Common stock, shares outstanding	35,074,605	34,874,605
Common stock share issued for service, shares	200,000
Shares reserved for future issuance, amount	$ 80,000	$ 180,000
Common stock to be issued	320,000	520,000
Share price	$ 0.50

XML 25 agtx_10q_htm.xml IDEA: XBRL DOCUMENT 0001603345 2021-09-01 2021-11-30 0001603345 agtx:GraysPeakMember 2021-11-30 0001603345 agtx:GraysPeakMember 2021-08-31 0001603345 srt:ChiefExecutiveOfficerMember 2021-08-31 0001603345 srt:ChiefExecutiveOfficerMember 2021-11-30 0001603345 srt:ChiefExecutiveOfficerMember 2021-09-01 2021-11-30 0001603345 agtx:ShareholderMember 2021-08-31 0001603345 agtx:ShareholderMember 2021-11-30 0001603345 agtx:ShareholderMember 2021-09-01 2021-11-30 0001603345 agtx:SBSManagementMember 2020-09-01 2020-11-30 0001603345 agtx:SBSManagementMember 2021-09-01 2021-11-30 0001603345 agtx:SBSManagementMember 2020-11-30 0001603345 agtx:SBSManagementMember 2021-08-31 0001603345 agtx:SBSManagementMember 2021-11-30 0001603345 agtx:GSLHealthcareMember 2021-11-30 0001603345 agtx:GSLHealthcareMember 2021-09-01 2021-11-30 0001603345 us-gaap:RetainedEarningsMember 2021-11-30 0001603345 us-gaap:AdditionalPaidInCapitalMember 2021-11-30 0001603345 agtx:CommonStockToBeIssuedMember 2021-11-30 0001603345 us-gaap:CommonStockMember 2021-11-30 0001603345 us-gaap:RetainedEarningsMember 2021-09-01 2021-11-30 0001603345 us-gaap:AdditionalPaidInCapitalMember 2021-09-01 2021-11-30 0001603345 agtx:CommonStockToBeIssuedMember 2021-09-01 2021-11-30 0001603345 us-gaap:CommonStockMember 2021-09-01 2021-11-30 0001603345 us-gaap:RetainedEarningsMember 2021-08-31 0001603345 us-gaap:AdditionalPaidInCapitalMember 2021-08-31 0001603345 agtx:CommonStockToBeIssuedMember 2021-08-31 0001603345 us-gaap:CommonStockMember 2021-08-31 0001603345 2020-11-30 0001603345 us-gaap:RetainedEarningsMember 2020-11-30 0001603345 us-gaap:AdditionalPaidInCapitalMember 2020-11-30 0001603345 agtx:CommonStockToBeIssuedMember 2020-11-30 0001603345 us-gaap:CommonStockMember 2020-11-30 0001603345 us-gaap:RetainedEarningsMember 2020-09-01 2020-11-30 0001603345 2020-08-31 0001603345 us-gaap:RetainedEarningsMember 2020-08-31 0001603345 us-gaap:AdditionalPaidInCapitalMember 2020-08-31 0001603345 agtx:CommonStockToBeIssuedMember 2020-08-31 0001603345 us-gaap:CommonStockMember 2020-08-31 0001603345 2020-09-01 2020-11-30 0001603345 2021-08-31 0001603345 2021-11-30 0001603345 2022-01-10 iso4217:USD shares iso4217:USD shares pure 0001603345 false --08-31 Q1 2022 false false

0.001

50000000

35074605

10-Q true 2021-11-30 000-55383 AGENTIX CORP. NV 46-2876282 32932 Pacific Coast Highway #14-254 Dana Point CA 92629 949 933-5411 Yes Yes Non-accelerated Filer true true false 35074605

1237

1768

49439

50676

51207

50676

51207

120771

121239

652289

485603

100

773160

606942

773160

606942

0.001

50000000

35074605

34874605

35075

34875

320000

520000

80000

180000

1033448

933648

-1871007

-1704258

-722484

-555735

50676

51207

108465

184563

42950

15488

15335

16667

166750

216718

-166750

-216718

0 -5

-166750

-216713

-166750

-216713

-0.00

-0.01

34965716

34489605

34874605

34875

180000

933648

-1704258

-555735

200000

200

-100000

99800

-166750

35074605

35075

80000

1033448

-1871007

-722484

34489605

34490

552883

-363911

223462

-216713

34489605

34490

552883

-580624

6749

-166750

-216713

166219

-14949

-531

-231662

-531

-231662

1768

242750

1237

11088

Note 1 - Organization and Basis of Presentation Description of the Company FairWind Energy, Inc. (the “Company”, “Fairwind Energy”) was incorporated on April 18, 2013 under the laws of the State of Nevada. Effective June 17, 2019, the Company changed its name to Agentix Corp. The Company is focused on the development of synthetic agonists, inverse agonists and antagonists which modulate the endocannabinoid system (ECS). The ECS is a network of G-protein coupled receptors (GPCRs) that help regulate a variety of metabolic and neurotransmission functions. Merger with GSL Healthcare, Inc. On May 28, 2020, the Company, entered into a Share Exchange Agreement (the “Share Exchange Agreement”), by and among the Company, and GSL Healthcare, Inc., a Nevada corporation (“GSL Healthcare”), and the holders of common stock of GSL Healthcare, which consisted of two stockholders. The closing date occurred on June 1, 2020. Under the terms and conditions of the Share Exchange Agreement, the Company offered and sold 27,932,271 shares of common stock of the Company in consideration for all of the issued and outstanding shares of common stock of GSL Healthcare. The effect of the issuance is that former GSL Healthcare shareholders hold approximately 88.0% of the then issued shares of common stock of the Company, and GSL Healthcare is a wholly-owned subsidiary of the Company. The merger between the Company and GSL Healthcare was treated as a reverse capitalization for financial statement reporting purposes with GSL Healthcare deemed the accounting acquirer and the Company deemed the accounting acquiree. Accordingly, GSL Healthcare’ assets, liabilities and results of operations became the historical financial statements of the Company. Prior to the Share Exchange, 3,806,613 shares of the Company’s then outstanding common stock remained outstanding as part of this merger. Merger with Applied Biopharma In July 2021, the Company entered into and completed an Agreement and Plan of Merger (the “Merger Agreement”), by and among the Company, AB Merger LLC, a Nevada limited liability company and wholly-owned subsidiary of the Company (“AB Merger”), and Applied Biopharma, pursuant to which Applied BioPharma merged into AB Merger and the effect of which is that, upon and assuming consummation of the Merger Agreement, Applied Biopharma became a wholly-owned subsidiary of the Company. The acquisition of Applied Biopharma was considered immaterial, as Applied Biopharma had minimal activity and had no assets or liabilities as of the date of merger. As such, the Company has included the activity of Applied Biopharma for the period following the completion of the Merger Agreement. Going Concern The Company’s unaudited consolidated financial statements have been prepared assuming that it will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business. As reflected in the unaudited consolidated financial statements, the Company had an accumulated deficit on November 30, 2021, a net loss, and net cash used in operating activities. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The Company is attempting to commence operations and generate sufficient revenue; however, the Company’s cash position is not sufficient to support its daily operations. While the Company believes in the viability of its strategy to commence operations and generate sufficient revenue and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon its ability to further implement its business plan and generate sufficient revenue and its ability to raise additional funds by way of a public or private offering. The unaudited consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. Principles of Consolidation The unaudited consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, GSL Healthcare, Inc., AB Merger LLC, and Applied Biopharma, all 100% owned entities. Intercompany transactions and balances have been eliminated in consolidation.

27932271

0.880

3806613

Note 2 - Significant and Critical Accounting Policies and Practices Basis of Presentation The accompanying unaudited consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), and with the rules and regulations of the United States Securities and Exchange Commission (“SEC”) to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited interim consolidated financial statements furnished reflect all adjustments (consisting of normal recurring accruals) which are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented. Unaudited interim results are not necessarily indicative of the results for the full fiscal year. These financial statements should be read in conjunction with the audited financial statements of the Company for the reporting period ended August 31, 2021 and notes thereto contained in the Company’s Annual Report on Form 10-K. Fair Value of Financial Instruments The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in generally accepted accounting principles (GAAP) and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below: <table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="width:9%;vertical-align:top;">Level 1</td><td style="vertical-align:top;">Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.</td></tr><tr style="height:15px"><td/><td/></tr><tr style="height:15px"><td style="vertical-align:top;">Level 2</td><td style="vertical-align:top;">Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.</td></tr><tr style="height:15px"><td/><td/></tr><tr style="height:15px"><td style="vertical-align:top;">Level 3</td><td style="vertical-align:top;">Pricing inputs that are generally unobservable inputs and not corroborated by market data.</td></tr></tbody></table> Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument. The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts payable and accrued expenses approximate their fair values because of the short maturity of these instruments. The Company’s equity investments are considered Level 3, as pricing inputs are generally unobservable and not corroborated by market data. Inventories Inventories are stated at the lower of cost or market. Cost is determined principally on a first-in-first-out average cost basis. Inventories consist of finished goods held for sale. Management regularly reviews inventory quantities on-hand and records an inventory provision for excess or obsolete inventory based on the future expected demand for products. Inventory write-downs are measured as the difference between the cost of the inventory and market value, based upon assumptions about future demand that are inherently difficult to assess. During the three months ended November 30, 2021, the Company did not record a provision for excess or obsolete inventory. Research and Development The Company follows paragraph 730-10-25-1 of the FASB Accounting Standards Codification (formerly Statement of Financial Accounting Standards No. 2 ”Accounting for Research and Development Costs”) and paragraph 730-20-25-11 of the FASB Accounting Standards Codification (formerly Statement of Financial Accounting Standards No. 68 ”Research and Development Arrangements”) for research and development costs. Research and development costs are charged to expense as incurred. Research and development costs consist primarily of remuneration for material and testing costs for research and development. Related Parties The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions. Pursuant to Section 850-10-20 the related parties include a. affiliates (“Affiliate” means, with respect to any specified Person, any other Person that, directly or indirectly through one or more intermediaries, controls, is controlled by or is under common control with such Person, as such terms are used in and construed under Rule 405 under the Securities Act) of the Company; b. entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c. trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d. principal owners of the Company; e. management of the Company; f. other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g. other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a. the nature of the relationship(s) involved; b. a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c. the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d. amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement. Deferred Tax Assets and Income Tax Provision The Company accounts for income taxes under Section 740-10-30 of the FASB Accounting Standards Codification. Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the statements of operations in the period that includes the enactment date. The Company adopted section 740-10-25 of the FASB Accounting Standards Codification (“Section 740-10-25”). Section 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under Section 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Section 740-10-25 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. Earnings per Share Earnings per share (“EPS”) are the amount of earnings attributable to each share of common stock. For convenience, the term is used to refer to either earnings or loss per share. EPS is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Pursuant to ASC Paragraphs 260-10-45-10 through 260-10-45-16, basic EPS shall be computed by dividing income available to common stockholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) during the period. Income available to common stockholders shall be computed by deducting both the dividends declared in the period on preferred stock (whether or not paid) and the dividends accumulated for the period on cumulative preferred stock (whether or not earned) from income from continuing operations (if that amount appears in the income statement) and also from net income. The computation of diluted EPS is similar to the computation of basic EPS except that the denominator is increased to include the number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued during the period to reflect the potential dilution that could occur from common shares issuable through contingent shares issuance arrangement, stock options or warrants. Pursuant to ASC Paragraphs 260-10-45-45-21 through 260-10-45-45-23 Diluted EPS shall be based on the most advantageous conversion rate or exercise price from the standpoint of the security holder. The dilutive effect of outstanding call options and warrants (and their equivalents) issued by the reporting entity shall be reflected in diluted EPS by application of the treasury stock method unless the provisions of paragraphs 260-10-45-35 through 45-36 and 260-10-55-8 through 55-11 require that another method be applied. Equivalents of options and warrants include non-vested stock granted to employees, stock purchase contracts, and partially paid stock subscriptions (see paragraph 260–10–55–23). Anti-dilutive contracts, such as purchased put options and purchased call options, shall be excluded from diluted EPS. Under the treasury stock method: a. Exercise of options and warrants shall be assumed at the beginning of the period (or at time of issuance, if later) and common shares shall be assumed to be issued. b. The proceeds from exercise shall be assumed to be used to purchase common stock at the average market price during the period. (See paragraphs 260-10-45-29 and 260-10-55-4 through 55-5.) c. The incremental shares (the difference between the number of shares assumed issued and the number of shares assumed purchased) shall be included in the denominator of the diluted EPS computation. There were no dilutive common shares for the three months ended November 30, 2021. Stock-Based Payments Stock-based compensation is accounted for based on the requirements of the Share-Based Payment Topic of ASC 718, “Compensation — Stock Compensation” (“ASC 718”), which requires recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). ASC 718 also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award. For non-employees, the Company follows ASU No. 2018-07, Compensation - Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. Under the ASU No. 2017-07, most of the guidance on stock payments to nonemployees is aligned with the requirements for share-based payments granted to employees. As such, most of the guidance in ASC 718 associated with employee share-based payments, including most requirements related to classification and measurement, applies to nonemployee share-based payment arrangements. No stock options or warrants were issued or outstanding as of November 30, 2021. Recent Accounting Pronouncements In December 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes,” which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. ASU 2019-12 was effective for the Company beginning in fiscal 2022. Adoption of ASU 2019-12 did not have an impact on the Company’s financial statements. On August 5, 2020 the FASB issued the ASU 2020-06 “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging— Contracts in Entity’s Own Equity (Subtopic 815-40)”. The amendments in this update address issues identified as a result of the complexity associated with applying generally accepted accounting principles for certain financial instruments with characteristics of liabilities and equity. For convertible instruments, accounting models for specific features are removed and amendments to the disclosure requirements are included. For contracts in an entity’s own equity, simplifies the settlement assessment by removing some requirements. Additionally, the amendments in this update affect the diluted EPS calculation for instruments that may be settled in cash or shares and for convertible instruments. The amendments in this update are effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. The Company is assessing the effects, if any, that the adoption of this accounting pronouncement may have on its financial statements.

The accompanying unaudited consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), and with the rules and regulations of the United States Securities and Exchange Commission (“SEC”) to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited interim consolidated financial statements furnished reflect all adjustments (consisting of normal recurring accruals) which are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented. Unaudited interim results are not necessarily indicative of the results for the full fiscal year. These financial statements should be read in conjunction with the audited financial statements of the Company for the reporting period ended August 31, 2021 and notes thereto contained in the Company’s Annual Report on Form 10-K.

The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in generally accepted accounting principles (GAAP) and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below: <table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="width:9%;vertical-align:top;">Level 1</td><td style="vertical-align:top;">Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.</td></tr><tr style="height:15px"><td/><td/></tr><tr style="height:15px"><td style="vertical-align:top;">Level 2</td><td style="vertical-align:top;">Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.</td></tr><tr style="height:15px"><td/><td/></tr><tr style="height:15px"><td style="vertical-align:top;">Level 3</td><td style="vertical-align:top;">Pricing inputs that are generally unobservable inputs and not corroborated by market data.</td></tr></tbody></table> Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument. The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts payable and accrued expenses approximate their fair values because of the short maturity of these instruments. The Company’s equity investments are considered Level 3, as pricing inputs are generally unobservable and not corroborated by market data.

Inventories are stated at the lower of cost or market. Cost is determined principally on a first-in-first-out average cost basis. Inventories consist of finished goods held for sale. Management regularly reviews inventory quantities on-hand and records an inventory provision for excess or obsolete inventory based on the future expected demand for products. Inventory write-downs are measured as the difference between the cost of the inventory and market value, based upon assumptions about future demand that are inherently difficult to assess. During the three months ended November 30, 2021, the Company did not record a provision for excess or obsolete inventory.

The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions. Pursuant to Section 850-10-20 the related parties include a. affiliates (“Affiliate” means, with respect to any specified Person, any other Person that, directly or indirectly through one or more intermediaries, controls, is controlled by or is under common control with such Person, as such terms are used in and construed under Rule 405 under the Securities Act) of the Company; b. entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c. trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d. principal owners of the Company; e. management of the Company; f. other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g. other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a. the nature of the relationship(s) involved; b. a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c. the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d. amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

Earnings per share (“EPS”) are the amount of earnings attributable to each share of common stock. For convenience, the term is used to refer to either earnings or loss per share. EPS is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Pursuant to ASC Paragraphs 260-10-45-10 through 260-10-45-16, basic EPS shall be computed by dividing income available to common stockholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) during the period. Income available to common stockholders shall be computed by deducting both the dividends declared in the period on preferred stock (whether or not paid) and the dividends accumulated for the period on cumulative preferred stock (whether or not earned) from income from continuing operations (if that amount appears in the income statement) and also from net income. The computation of diluted EPS is similar to the computation of basic EPS except that the denominator is increased to include the number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued during the period to reflect the potential dilution that could occur from common shares issuable through contingent shares issuance arrangement, stock options or warrants. Pursuant to ASC Paragraphs 260-10-45-45-21 through 260-10-45-45-23 Diluted EPS shall be based on the most advantageous conversion rate or exercise price from the standpoint of the security holder. The dilutive effect of outstanding call options and warrants (and their equivalents) issued by the reporting entity shall be reflected in diluted EPS by application of the treasury stock method unless the provisions of paragraphs 260-10-45-35 through 45-36 and 260-10-55-8 through 55-11 require that another method be applied. Equivalents of options and warrants include non-vested stock granted to employees, stock purchase contracts, and partially paid stock subscriptions (see paragraph 260–10–55–23). Anti-dilutive contracts, such as purchased put options and purchased call options, shall be excluded from diluted EPS. Under the treasury stock method: a. Exercise of options and warrants shall be assumed at the beginning of the period (or at time of issuance, if later) and common shares shall be assumed to be issued. b. The proceeds from exercise shall be assumed to be used to purchase common stock at the average market price during the period. (See paragraphs 260-10-45-29 and 260-10-55-4 through 55-5.) c. The incremental shares (the difference between the number of shares assumed issued and the number of shares assumed purchased) shall be included in the denominator of the diluted EPS computation. There were no dilutive common shares for the three months ended November 30, 2021.

Stock-based compensation is accounted for based on the requirements of the Share-Based Payment Topic of ASC 718, “Compensation — Stock Compensation” (“ASC 718”), which requires recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). ASC 718 also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award. For non-employees, the Company follows ASU No. 2018-07, Compensation - Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. Under the ASU No. 2017-07, most of the guidance on stock payments to nonemployees is aligned with the requirements for share-based payments granted to employees. As such, most of the guidance in ASC 718 associated with employee share-based payments, including most requirements related to classification and measurement, applies to nonemployee share-based payment arrangements. No stock options or warrants were issued or outstanding as of November 30, 2021.

In December 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes,” which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. ASU 2019-12 was effective for the Company beginning in fiscal 2022. Adoption of ASU 2019-12 did not have an impact on the Company’s financial statements. On August 5, 2020 the FASB issued the ASU 2020-06 “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging— Contracts in Entity’s Own Equity (Subtopic 815-40)”. The amendments in this update address issues identified as a result of the complexity associated with applying generally accepted accounting principles for certain financial instruments with characteristics of liabilities and equity. For convertible instruments, accounting models for specific features are removed and amendments to the disclosure requirements are included. For contracts in an entity’s own equity, simplifies the settlement assessment by removing some requirements. Additionally, the amendments in this update affect the diluted EPS calculation for instruments that may be settled in cash or shares and for convertible instruments. The amendments in this update are effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. The Company is assessing the effects, if any, that the adoption of this accounting pronouncement may have on its financial statements.

Note 3 – Related Parties During the three months ended November 30, 2021, the Company incurred $37,500 of management fees, $15,000 for reimbursement of rent and $15,187 of advances to the Company to cover certain operating expenses and accounts payable from SBS Management, a company controlled by Mr. Scott Stevens who is a shareholder of the Company. As of November 30, 2021, $191,420 was included in Accounts payable – related party on the accompanying unaudited balance sheet. During the three months ended November 30, 2020, the Company incurred $5,000 for reimbursement of rent and $1,003 of advances to the Company to cover certain operating expenses and accounts payable from SBS Management. As of August 31, 2021, $127,233 was owed to SBS Management and was included in Accounts payable – related party on the accompanying unaudited balance sheet. The advances are unsecured, non-interest bearing, with no formal terms of repayment. During the three months ended November 30, 2021, Gray’s Peak Capital, a company founded by Mr. Scott Stevens who is a shareholder of the Company, made advances to the Company to cover certain operating expenses. These advances are unsecured, non-interest bearing, with no formal terms of repayment. As of November 30, 2021 and August 31, 2021, the amounts due Gray’s Peak Capital for these advances was $155,370 and $120,870, respectively, and was included in accounts payable – related party on the accompanying balance sheet. During the three months ended November 30, 2021 the Company incurred $18,000 of consulting fees from a shareholder of the company of which $122,500 and $107,500 was included in accounts payable – related party on the accompanying balance sheet as of November 30, 2021 and August 31, 2021, respectively. During the three months ended November 30, 2021, the Company incurred $45,000 from a consulting and employment agreement with its CEO of which $175,000 and $130,000 was included in accounts payable – related party on the accompanying balance sheet as of November 30, 2021 and August 31, 2021, respectively.

37500

15000

15187

191420

5000

1003

127233

155370

120870

18000

122500

107500

45000

175000

130000

Note 4 – Equity As of November 30, 2021 and August 31, 2021, the Company has authorized 50,000,000 shares of common stock at a par value of $0.001 per share and had issued and outstanding shares of common stock of 35,074,605 and 34,874,605, respectively. Shares issued During the three months ended November 30, 2021, the Company issued 200,000 shares of its common stock sold at a price of $0.50 per share which was previously sold and reflected as common stock to be issued as of August 31, 2021. As of November 30, 2021 and August 31, 2021, the Company had not issued 320,000 and 520,000, respectively, of shares previously sold and as such, $80,000 and $180,000, respectively, was reflected in the accompanying consolidated balance sheet as common stock to be issued.

50000000

0.001

35074605

34874605

200000

0.50

320000

520000

80000 180000

Note 5 – Subsequent Events In accordance with ASC 855, the Company has analyzed its operations subsequent to November 30, 2021 through the date these financial statements were issued and has determined that it does not have any material subsequent events to disclose in these financial statements.

EXCEL 26 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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
!TDH!K>[N=D*UC/VTL<7?&8&ULU3QINIIJTG M[>1&W:GNU]U'!U?G"4JM6V6\MD8XM7Y]O#%;X&DK*S] M#2\^U*]/YHB1:E35(0@)_[M7MZII$!+@\7L >I+VQ(7E[PC]>R(>B%E)KVYM M\P]==]O7)]^-VK^8FH>M_9-BP&#%IM M^/_R#ZT()E6$",..>-",MWLI-O7CG[(!R^#=#P!Y%*JP$Y;5 J=YV# MIQK6=6_N],;HM:ZDZ80TM;AUNH.K1MQ4E>U-I\U&?+2-KK3R],)'AXRLX.HT MWC][==X!*@CPO K;ON5MEP>VO1 _6M-MO7AO:E4/UY\#"8F.9:3C[?(HP)_L M_4Q8?!0,&O0+OY.5>GVR0T#N7IV\$9^V"FRALNU.FDRKW6G:E%9XX&F M6N+%6AMI*@TD>T! @25V3*E3#;U@; >T;^6]$BNEC( ]=M+! VUH U?#>@7Z MW&WI.G!MYS2 W36P=J.,Z7KP\FQ!NM!D"<'VC(KJ;OB$.$J"GT.]4U:-TP_OO M/U=;:39*W-JVU9[<3]SU[OUMW$]T5J!?$(OY]&^T\,:!_!LEKG&;7]*NXF[Z M/S-2&U<#_!:R-AVPLOT*8:][9S2X%N3A&MTH(2GK?X);XC=. M$8CV)%<@VB#F#;P-#'5X#\3J>MGX,_&PU16H@5.3*&*[TP:)A'6M-! !$.1$ M& 4VY"% ((.E6$OM,DY1@*#-X'4]$<],8YIV\*^MO=BQW:AZ!K+>)SPN!F1( M G%'#7JH30U:AH'BT%;K'GBPUAY]P:.2CMCKQUDO_-;V#0@,P4A2;F#8/WO# M$2DI:\1P%$; XY8--N$!QF8=&Q01+11Z4G'3;T ZXF+!GI!4B-4'%CD%/ 4, M.HC6V=8"9%3LQ=5++VZ, 9F!!N,& O",:OY?,W'$N5TFYW9YU+E]CQ+]NVQZ M8O'WB>0/QG>N)YK'7-U1H$=<7>9; QD(J(9TV=/'@(DPM':C4K:TI'I#D4 @UZ$!C?>_0;ZP@X6%=O8^4:52:1)W.U)%, M2C00@>G%Y?3BZAO1B&[IXRBPTE.U2B*FK,%?A^9,C(,5"I1SU:!C\&B@3K8* M,R]B"N^#*!>[@)Z->/KQD'"*3NV,6*0^@^" Y*.,#H1%3V?1GX*M@4$&UZ1, M]4C@*.(YN=*-[M#0#T$9Q+AB[\E7\B-#W6J@V57;Q^#]@$R+@>8/MD; 8=?# M?B >?)]%VJEJ:_3O/;S2>T"@D-V HW"_VSJEQ.G%F5@Y"]ZE4?>J">Y^%(L- MN#7>>0NY*J =,2)?^WMOD6*X1F-7:*3 M\@&QCO3Q-2@AH[2 HDW^3"(A0?$@NZ] M5KYR>H7O8?WQ0OPW0A4+\3@$9TSAM=9V'8)^1PD MC' W2-ZB3X8%TNQQ_^G^(4T@IQV(F.2@*I0F4#7D!U4'5H;8FGR5F?TE'"_V M<03L.MHBF_"(]&*< 2MSSJZL(^L!X00.PQ9R5CC[P$"$2W9:*TQL(@H/6T6A M">2>A>^#1"&(MR3ZW@??0>BVM@9]F9#%HE_!=%;ZK5B#W,&$NJVM;6,W*"=@ MCM_#NG1* M^\Z' L<3\<$6Y99KS \QJP&,6TNK0+61EV3-A3F"'[]7E B#E#JU =3^8 <( M_,0JN\;$HT"? 3#+227AO5) Y _5 9\>53Y'-Q93)9VC$DBVJ#+[N5;*B+Y$ M^$3X'@W1D\I-8FC#9..1K<[4G LK"FO*>!30;N?L9PVYOAI1]I6J) @AH@29 M)"1C\&Y/0N2[7@T#]J<1W+%HH'@'RA>R]G&KFR#^NZ'Q'['[KS+X(^GB\Y0N M/C^:+GX Q"':.;U?67-:>'3Q@;2P $D44K)-QA\5SB&#*XN.P 6*9L!93VI7 MN*"0N!!WL%X#37&^FVHSY1^8K$!]#/%),;@55O:S 08A3Z%(IT.]M;%8Q6Q5 M4Y.I>XF.Y<=4)86:UL&N3MUCHXKDBQ ?P9& /; ]6C/=DNI11H,%**IN\2XH MX+WV,:-5G[$00I)!SI8*ROSJP"C7?8=. 56YHC1)M5RK.@19]U57$ GI#^BL MFM;VP3##@VG6J'$(#E+:-:@B=@M6JGM0[/V# *+I1F"X45 R,I5)0*W?H022 MATZY(J,:,$S13!LLAPQ&1]Q=5U#D4<4)!NX!^7>/4.S=ON#A961T'] MJ<+JZH+2,"ROOK6@P=Z'0KV^*TO^G#>,@OC)SB"W"N5.\0;R^A KR)I]6!/7 M'GSYQCEL"1$/XYHCH( M,1A+4W O\07&EC**A)GG:X3.+I3R,VU"94M) /I O=+#_'YV?PR7"(;BQ[G M3=6=[24Z+\5J)E2,&BALKBS*I$''C#PD%#Y#?,A-+NY0 L(K[+_1'FD $_8L MVP^<2V4E)3B+EXMY_'$Y0CU2-CP5AS M(1!O,GVH]T0\\*&:@89"VIW[?2M(?]::W)!J=XU]5&6^MPOS*6KI. LO3OU6 M#7NA+T4]RQF&@.@)VO!$J+"$.672;KBW M$X0C<'G N\7I&DH7_-R]8NDZVU([%O(8]".4 MMV(2_P"8XBA"=L$B0\#8Z%873=93^/%![;\C0V.!0H)F6G!/MX8'5A M0E($YDDLK7!,81]P^.1Y*L2K8\T/N6@;_9F@H0Q.&\!G."ZW5MA8H"3P!R@% M('N?[$6T$K5LWZH!^$860RP>B*50.1BX\-1F157$*,\@.' *&88^!--Z]62R M4[)SP.@7&"01#R.[WA4#C3 - QT\]=A=N+?-O:HI",A0H^]*CST4!4-G#U?R MP0:W8FPNIQU<(5.:= MJ*VQ"<1M@PNFPA%5AJSC *6,0\$D-9I!.Y0$/"YC< M,4NYG)_5"I;4>R.E$&\\9CIA;D4! DJ0JGMJRC0V-'O]CXP-APP4 T1V4*ZR MDU""^)<)3?V< E'TW&%8&50NQ#<,5K$KGJZ1G'_YDCZ_5U*O[\[FGZ_4U!UHFU]DI_%3>[L?&!)X-V/ ML7 ;R\V/0O^*W#RUB:B=QYMV\K.*:6',=JZ><5O[&[-V*&(C@1GXH=;=7F^U M**ES<>X'U7FVAMQ))AV%37 Y:^B!W; I438"N)=+ZFTDM100C*/DGA;+A^!J M'S1XN!4I/%M"ZA8/,)5E>X(T%ARY5P5/2F8X=(MU7W%Z)HMY3 HEL<,80FN1 M$H!?)W\+/IOZ0Q1I&_V;HB(!_ VJ.>%.LU[>DLC !SP;;O0?.*P>16Y$4GM\ M>\JSDG2PJX9<'SP.'5_2AF#[.,2F/[*^&X_&0D*&;C?Z,1^+<*([22=I% M4N.AQ\ <:TN#23\TN^7EGYS*WNW#B0/9V;YEPQ:RKL%)^(!FM,24.X".7EL-N%M4,2 M$?ONC"5'#0JZE7)X\(">[JS73)O!1';]5:8S6!C]@(?JB8\S6,Q[9>):J/%@ M$7FF'A3;A6[]H)?)(R"?TUG(&L%)(>'0N M[,S[IN.!0QE*1[2Q\9:;EF@XFU[S42ZRY6F@'I=,4-.\3[H_R44-5<1@;DWH M1 \"W*2<_FOSY/P.-ZPI\_5IHC^8QA]- !;S?/IQ?C0%>"^= 1RPD <]A\I= MC9YE/ KD0*0?@,:F@$J>X?W'NW0X0X;A&F=:G#J%A;+K($WN.W+:8-B44S$D M*B>H:>0[6_TVPS,Z&(B@YZ2O6*5EWTD,OGI##/OM%##OM^-W>W>83O,TSL4L8>6W'S.9FOK@A!KG?0 MX44T5QBQ0&U9L4CC\EB?3C]EKFUM@X6 .*4BJ6\QBEAW%CW' YWH5?4T3G#@ ME54<#3$49!5PK^]2-7'*[IO+'H)6YTD"J_ MX6SZ2QN@LN$TF[QB$ W]QBZ3-M1=*"+YJ5Z'VIH- [*8F*APZVY8+3'JY+<( MJ%%=>">,>HF#*9[6NB%^!BU/QP%L&#P-7L[ZAI.;71&1"D$CF.RI.IO:'4&Y M@N9 G"?/"9%BJ$2$G^A<\ M 1WHY$ 7 3'LT/C&C@@@8T'^+@JJW ?!L_(&(V4Y;C =_TJ_ /\M%R.N >]?B'>%9)/]#")LBV-%6=_#/F#5MO?L.!U_:$#U M*R94$%FQ*J4#&;%L)H4S]<[JW&L-C?!'P58;FS)!2C$+7@]D62%>D0-T;CFP M0)P&"PR-=BA$,)4XB\(,KBE77-RXSI0&P;('*+4-#B@Y,Y *( I+]J-R>/B,@D#KYX30>'QY>7T.CV%B\4BQO5@W(:[-K$O MKQA)K"'>9_(YR1_A5K0Q8\T46_G)^6SP.=MAV;6G9Q#)H-#@$X(=GMH/74)J M9M H'WUA>-GWJ]0/ ^EXI8I!)Q"Y/X:XC(.)Y07D^3<@G6G2A6*_-#\(N&!\ M[08TYB>ELDRRI,$7\8DPTLU"U#%M/RA?:@R^CPI^B+=I(YJIY_,1*[71QA2= ML^!53L%J\!4H/.A<:;!]:O1@^'!G\1AFX42>;,+U"VO[##N2GU@)*Z7JD%$G MTSRP.&8[A9QS:(U4Q)A>G@ <"]6G=Z7$2[5??K>GZ,]*1;^90>7QP/W#9(K $9U$$0*+!*6[< M&BL*;2X%&5.#KSDL<3QW+[Y<6AS-W>]0GM.W9",?Y>/! P['P1S(WADXQXW! MQ$'[_0%C&5N"R8HBG^$2S>/RN!:+)Z(D)I<%ON1:YD^9*1$>6C M.-].@V\&DS^&X69.JJ&*FNUHR1I0CB=OHN\,8WVT:.6PN1_";D!B?V^R M;MK\%.5)QX'N5?CL1L2!+^^,+IHYQZECXM?(X<&_C"<#A:% -:6N^?!SJ\F X41TQ$M$J>LAT#_V0OQH<5@'Q0! MN/V3-8G6,1W.=5X9<0HLK@B+MCC%57820C .AHL;FKPA]?UDHS?8V,D?=976 M10?C""UF:((T%OM!SGR$X@ ^(*RD"-[;2E.]0QLG'HQM5H[#"/ Q3@FP?)N MT"?AN4;6L4E(>_;9,+;G8.8Y UX?3JC9:8>X@9Z^2$%Y9/.-OGF9??/R"R>; MJJ&*X"3%6&P"'O;31T$>/,LIWL%>1 .HW'>3W(<(=*-"XI/I8IF\;)[P8# . M1O!L#D9PIX'U>OT8\X"]XV3EPDETPF%^YZF-12$/>R0!$%@T>)H>P_..YG:% M4L@A\+)#-BOQAC6MQ"]1EJMC[ _@L:?PT=\R2"P@&5_D#^DZ((RGIH 7"0/$PJX(^>SR^;USR9^#7=)NCU_HAK17^'#Z?QYU(YW M:M6%T(L_V0WW:%1]?.P@E"!Q5,1\?^\?H'50,? M-C&JW\9R +GRGNJX1-'/#X8*( B<&?;U I+,^5E0.TXN28#%"2WL]NTHG(2) M M/JT]$]/G4KPW>-.;CA%Z2?<;]]_T?C(]*-K_V&BSY)#9HZ_@4< 8;8B.0# MDT#W*G)'^S-"SAV*[B94:#S!2K &K63^"(1# Q_OJ\1:T?&'..5#0ZJS[J?@ MTPV.4@S].!\8Y@PZ(9-EAP=NAN+#$S*,^R0Z AU&.[GQ'LX:T\_5(Z.&1'AT M N7^:":Q:Q3SF"-RYX[#DY1>-E7$IF=318'E>(XQEE%_/A;5?Q^)D99+^() M[P."^*(^.K7G(HJO:'WA(^0:AQS)JR\NXQ%K1&!_4A"^-N&I90EP.-O3/G [ MC9GY% 55I_#"I!C0%BZ)\!\H>1'$B&/DH#"I[@ZXH;%P>E[\O896N0W]50IL M0\$V_*<;TMWTER]N^.\]Y-?YSV;\*!WPS8M&K6'I?'9U>2(<_R4*O@#707_] M866[SK;T&PO=V]R:W-H965T FMXFUQ"ZVTVS\>FPGS=HM"R^\-/ZX MY]QSKMWKN&'\3A0 $MU7)15SJY!R?V';(BV@PF+"]D#5SH[Q"DLUY;DM]AQP M9D!5:7N.$]H5)M1*8K.VYDG,:ED2"FN.1%U5F#\LH&3-W'*MX\(MR0NI%^PD MWN,<-B"_[==R>)2,54$$811QV<^O2O5A&.MX$?"?0B),QTDZVC-WIR>=L M;CE:$)202LV U>< 2RA+3:1D_.XXK3ZE!IZ.C^P?C7?E98L%+%GY@V2RF%N1 MA3+8X;J4MZRYALY/H/E25@KSBYHV-E3!:2TDJSJP4E 1VG[Q?5>'$X#B&09X M'W-:496F!!!&([M.8@@,IVY_452$Q*@6XPYUA7_@UZAT2!55!L2R5$ MT]EIEW31)O5>2.JC%:.R$.@#S2 [Q]O*0._".[I8>*.$-^PP0;[S%GF.YP[H M68[#+^MCS,O6^D9;1QM69D/^@V>VO-E[W_-F[K"ML$\>CB9? T_U]0#>I0XI&BDG1?[NLT?,[&#EAZ/I/SLH^:4@5\-ST::'H:RK;WM2O]D_!I>F ]F-X^XZL M,,$%:B$G8(ZDYG*SMO>W$XDVYOVMF52-4LS+-1S!EP'J/T=8_(XT0GZ!S+Y M"U!+ P04 " C:2U4TZQN/UL# #Q"P &0 'AL+W=OT8ZE 5CS_KP+1P86"N"!)924U#ULX,))(EF4CK^E*1& MY5,#Z\]O[)_SX%4P"RI@PI*?<2BC@1$8*(05W2;RD>V_0AF0J_F6+!'Y7[0O M;!W/0,NMD"PMP4I!&F?%+WTI$U$#*)YF@%4"K%. TP*P2X!]*F2*4 M/ ]3*NFPS]D><6VMV/1#GLP3J;:QPII/T=6'Z[XIE4L--)%$![C M326UTFN]Z1U;G80/;'>#;/P16=@B#7HFE\-Q WS:#1]MUPI.FKP?16-7V;=S M/J>%;\(RH1HTSM9H!2":\EL0>#F!_HAW0X(#QW/[YJX>=H-9X+B>79D=Z7,J M?4ZGOGE$.40L"8&C7_>0+H#_[@C;K6C=3MK1Y5L[[W5\L[U!;C-KU_Y];NK M@,9HCNYII@:Q&KGRDE($%7?PGTH1G(?:(XYU6HH&,\NW[);&[%6R>YVR'W4: MX$7]]Q/0)*YW[M7%IVTR.;=R6XM%\&&BXDYMM4*UM4G)4/=LM_S98M/TI 3$O@G.2G-CK\=W%(N8AV46=W?SMWW2]J6'"8GZ1Z=_]ZX)?%1 M(OSS[I@VV=FXO4$.0Y5T3]4+YDC)4/?M=/3F8?"2[LG[A=-7@69 GR^JQF$R MDN[1^(YJ>.?]YKJV?U:-!CL+!_YI2LS:+I0"7^<[I4"YO&+-J&ZKO764;VLG M]V-R.RFVSP--L0S?4[Z.,X$26"E*?..KG/-BORP.DFWRC6O!I-K?\L=([>3 MM8%ZOV),OAVT@VK+'_X%4$L#!!0 ( "-I+52MUEJ+Z@( &() 9 M>&PO=V]R:W-H965T_+>(R3 M6UD0OK!R(:HKV^9)CDK()[1"1)[94%9"(:$YK46""'AG@=5E"]O<&%72WL%QKO_"$LURH!3N>5S!#*R2>JT[5TM4!'_,9HQSMCH%)94_JB)K_2A>4H(E2@1"@+* ]; MM$1%H9PDQVMC:K775,+N>._^0R:RS^@K-;)" N M.'B C$%5V7/P'3RO;L'9M_.Y+>255+R=-*XWQM4[XNJ#>TI$SL$=25':U]N2 ML,7T]I@WWJCA ]U.@.]< ,_QW &>Y;C\NLZDW!V2]W#\MFJ^]O-'JS9B-&V- MIMIH>L1H2^,VTG_J/;F-GXC@RJ6VW M')]%]6"#%C;X.BRL14X9_G>XS8;6& 8=CL QGP/@$P)[S&'+''Z=&7->#_.& M'S#\P)E-0R) H* MEK0F8@C*F(<=J&C@QOT8Y4;'T5WG_;GLG%Y30<$:C=RVC5=O9[T!V(&XP!NA M[701]_-2@XK)?1[D,^JH]SPZO.GL3A/>\@R3#@HT$9*G&POWW./[XX8==;H#:?7*TJUMZZX:%)_I77],0B:Y8I6 MI#F7-14&*:2JB#93509-K2C)&W"J># >C>*@(DSX\YEHJ\M*-]Y2MD*G?C28 M/'O[DJ=^&+_W/4N7R9RF_NWIVY^MU!=O/'L_>7=R,KH]NSBVGW; F1\X22=/ M(#T?C7!B #'R^&GDCW%WU$&?H/FLD.(P3V PL4E%O3O"4S\CG"T4 Z^"5(QO MK'D,AJ7D4GG:%,B("<'2W%LXM#.H7<]3,2%5%]M&L-^+?OD1L)V!0,;Y('#L M6\-\5A.MJ1*79M(M[HP/(*\?WVQJH[!49!..)_[.H;N9( NI&=DDYOX;&_E$<<*^+O:J.H*9B M&!I!_=#2V GP[[-9[CW:Y%FT7LWNI/[:_F^>2"JH(WQ=M6O\E9_G9BJ,/_TIR]Z-R+-BIL3^L7KK(R6L0 M&;](D4'_@[YW:AR<&8/5@[,Y];_#>P#?!?46+>.:B7ZV8GE.Q8.CP]!KLC!O M6@?\9GU."])R?3. J;\;?Z,Y:ZMD6'4%B>A7[<9?87MA/+P8F%A,Y'1-\ZR? MJG+1#3TS,%'["QR.D@?BN^- 3[E] MH@BJBFG#GF <21(,@5YT]V@<(]F)X>.N#_:41%&2N!' W JB"$/@:<013 %H MP) HZL[!H_,HV)Y3P>[?#_/?4$L#!!0 ( "-I+527BKL
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end XML 27 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 28 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 29 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.4 html 43 183 1 false 9 0 false 4 false false R1.htm 000001 - Document - Cover Sheet http://agentix.com/role/Cover Cover Cover 1 false false R2.htm 000002 - Statement - Consolidated Balance Sheets Sheet http://agentix.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://agentix.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 000004 - Statement - Unaudited Consolidated Statement of Operations Sheet http://agentix.com/role/UnauditedConsolidatedStatementOfOperations Unaudited Consolidated Statement of Operations Statements 4 false false R5.htm 000005 - Statement - Unaudited Consolidated Statement of Changes in Stockholders (Deficit) Equity Sheet http://agentix.com/role/UnauditedConsolidatedStatementOfChangesInStockholdersDeficitEquity Unaudited Consolidated Statement of Changes in Stockholders (Deficit) Equity Statements 5 false false R6.htm 000006 - Statement - Unaudited Consolidated Statement of Cash Flows Sheet http://agentix.com/role/UnauditedConsolidatedStatementOfCashFlows Unaudited Consolidated Statement of Cash Flows Statements 6 false false R7.htm 000007 - Disclosure - Organization and Basis of Presentation Sheet http://agentix.com/role/OrganizationAndBasisOfPresentation Organization and Basis of Presentation Notes 7 false false R8.htm 000008 - Disclosure - Significant and Critical Accounting Policies and Practices Sheet http://agentix.com/role/SignificantAndCriticalAccountingPoliciesAndPractices Significant and Critical Accounting Policies and Practices Notes 8 false false R9.htm 000009 - Disclosure - Related Parties Sheet http://agentix.com/role/RelatedParties Related Parties Notes 9 false false R10.htm 000010 - Disclosure - Equity Sheet http://agentix.com/role/Equity Equity Notes 10 false false R11.htm 000011 - Disclosure - Subsequent Events Sheet http://agentix.com/role/SubsequentEvents Subsequent Events Notes 11 false false R12.htm 000012 - Disclosure - Significant and Critical Accounting Policies and Practices (Policies) Sheet http://agentix.com/role/SignificantAndCriticalAccountingPoliciesAndPracticesPolicies Significant and Critical Accounting Policies and Practices (Policies) Policies http://agentix.com/role/SignificantAndCriticalAccountingPoliciesAndPractices 12 false false R13.htm 000013 - Disclosure - Organization and Basis of Presentation (Details Narrative) Sheet http://agentix.com/role/OrganizationAndBasisOfPresentationDetailsNarrative Organization and Basis of Presentation (Details Narrative) Details http://agentix.com/role/OrganizationAndBasisOfPresentation 13 false false R14.htm 000014 - Disclosure - Related Parties (Details Narrative) Sheet http://agentix.com/role/RelatedPartiesDetailsNarrative Related Parties (Details Narrative) Details http://agentix.com/role/RelatedParties 14 false false R15.htm 000015 - Disclosure - Equity (Details Narrative) Sheet http://agentix.com/role/EquityDetailsNarrative Equity (Details Narrative) Details http://agentix.com/role/Equity 15 false false All Reports Book All Reports agtx_10q.htm agtx-20211130.xsd agtx-20211130_cal.xml agtx-20211130_def.xml agtx-20211130_lab.xml agtx-20211130_pre.xml agtx_ex311.htm agtx_ex312.htm agtx_ex321.htm http://fasb.org/srt/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 http://fasb.org/us-gaap/2020-01-31 true true JSON 32 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "agtx_10q.htm": { "axisCustom": 0, "axisStandard": 4, "contextCount": 43, "dts": { "calculationLink": { "local": [ "agtx-20211130_cal.xml" ] }, "definitionLink": { "local": [ "agtx-20211130_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "agtx_10q.htm" ] }, "labelLink": { "local": [ "agtx-20211130_lab.xml" ] }, "presentationLink": { "local": [ "agtx-20211130_pre.xml" ] }, "schema": { "local": [ "agtx-20211130.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd", "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd" ] } }, "elementCount": 135, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2020-01-31": 3, "http://xbrl.sec.gov/dei/2020-01-31": 7, "total": 10 }, "keyCustom": 4, "keyStandard": 179, "memberCustom": 5, "memberStandard": 4, "nsprefix": "agtx", "nsuri": "http://agentix.com/20211130", "report": { "R1": { "firstAnchor": { "ancestors": [ "strong", "span", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "agtx_10q.htm", "contextRef": "From2021-09-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000001 - Document - Cover", "role": "http://agentix.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "strong", "span", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "agtx_10q.htm", "contextRef": "From2021-09-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "agtx_10q.htm", "contextRef": "From2021-09-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000010 - Disclosure - Equity", "role": "http://agentix.com/role/Equity", "shortName": "Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "agtx_10q.htm", "contextRef": "From2021-09-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "agtx_10q.htm", "contextRef": "From2021-09-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000011 - Disclosure - Subsequent Events", "role": "http://agentix.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "agtx_10q.htm", "contextRef": "From2021-09-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "agtx_10q.htm", "contextRef": "From2021-09-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000012 - Disclosure - Significant and Critical Accounting Policies and Practices (Policies)", "role": "http://agentix.com/role/SignificantAndCriticalAccountingPoliciesAndPracticesPolicies", "shortName": "Significant and Critical Accounting Policies and Practices (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "agtx_10q.htm", "contextRef": "From2021-09-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "agtx_10q.htm", "contextRef": "AsOf2021-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000013 - Disclosure - Organization and Basis of Presentation (Details Narrative)", "role": "http://agentix.com/role/OrganizationAndBasisOfPresentationDetailsNarrative", "shortName": "Organization and Basis of Presentation (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "agtx_10q.htm", "contextRef": "From2021-09-01to2021-11-30_agtx_GSLHealthcareMember", "decimals": "0", "lang": null, "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "agtx_10q.htm", "contextRef": "From2021-09-01to2021-11-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfessionalFees", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000014 - Disclosure - Related Parties (Details Narrative)", "role": "http://agentix.com/role/RelatedPartiesDetailsNarrative", "shortName": "Related Parties (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "agtx_10q.htm", "contextRef": "AsOf2021-11-30_agtx_ShareholderMember", "decimals": "0", "lang": null, "name": "us-gaap:AccountsPayableOtherCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "agtx_10q.htm", "contextRef": "AsOf2021-11-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000015 - Disclosure - Equity (Details Narrative)", "role": "http://agentix.com/role/EquityDetailsNarrative", "shortName": "Equity (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "agtx_10q.htm", "contextRef": "From2021-09-01to2021-11-30", "decimals": "0", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesIssuedForServices", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "agtx_10q.htm", "contextRef": "AsOf2021-11-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000002 - Statement - Consolidated Balance Sheets", "role": "http://agentix.com/role/ConsolidatedBalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "agtx_10q.htm", "contextRef": "AsOf2021-11-30", "decimals": "0", "lang": null, "name": "us-gaap:InventoryNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "agtx_10q.htm", "contextRef": "AsOf2021-11-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "role": "http://agentix.com/role/ConsolidatedBalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "agtx_10q.htm", "contextRef": "From2021-09-01to2021-11-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfessionalFees", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000004 - Statement - Unaudited Consolidated Statement of Operations", "role": "http://agentix.com/role/UnauditedConsolidatedStatementOfOperations", "shortName": "Unaudited Consolidated Statement of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "agtx_10q.htm", "contextRef": "From2021-09-01to2021-11-30", "decimals": "0", "lang": null, "name": "us-gaap:ResearchAndDevelopmentExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "agtx_10q.htm", "contextRef": "AsOf2020-08-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000005 - Statement - Unaudited Consolidated Statement of Changes in Stockholders (Deficit) Equity", "role": "http://agentix.com/role/UnauditedConsolidatedStatementOfChangesInStockholdersDeficitEquity", "shortName": "Unaudited Consolidated Statement of Changes in Stockholders (Deficit) Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "agtx_10q.htm", "contextRef": "AsOf2020-08-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "agtx_10q.htm", "contextRef": "From2021-09-01to2021-11-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000006 - Statement - Unaudited Consolidated Statement of Cash Flows", "role": "http://agentix.com/role/UnauditedConsolidatedStatementOfCashFlows", "shortName": "Unaudited Consolidated Statement of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "agtx_10q.htm", "contextRef": "From2021-09-01to2021-11-30", "decimals": "0", "lang": null, "name": "us-gaap:IncreaseDecreaseInAccountsPayable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "agtx_10q.htm", "contextRef": "From2021-09-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000007 - Disclosure - Organization and Basis of Presentation", "role": "http://agentix.com/role/OrganizationAndBasisOfPresentation", "shortName": "Organization and Basis of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "agtx_10q.htm", "contextRef": "From2021-09-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "agtx_10q.htm", "contextRef": "From2021-09-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000008 - Disclosure - Significant and Critical Accounting Policies and Practices", "role": "http://agentix.com/role/SignificantAndCriticalAccountingPoliciesAndPractices", "shortName": "Significant and Critical Accounting Policies and Practices", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "agtx_10q.htm", "contextRef": "From2021-09-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "agtx_10q.htm", "contextRef": "From2021-09-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000009 - Disclosure - Related Parties", "role": "http://agentix.com/role/RelatedParties", "shortName": "Related Parties", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "agtx_10q.htm", "contextRef": "From2021-09-01to2021-11-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 9, "tag": { "agtx_CommonStockToBeIssuedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock To Be Issued [Member]" } } }, "localname": "CommonStockToBeIssuedMember", "nsuri": "http://agentix.com/20211130", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfChangesInStockholdersDeficitEquity" ], "xbrltype": "domainItemType" }, "agtx_DeferredTaxAssetsAndIncomeTaxProvisionPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets and Income Tax Provision" } } }, "localname": "DeferredTaxAssetsAndIncomeTaxProvisionPolicyTextBlock", "nsuri": "http://agentix.com/20211130", "presentation": [ "http://agentix.com/role/SignificantAndCriticalAccountingPoliciesAndPracticesPolicies" ], "xbrltype": "textBlockItemType" }, "agtx_GSLHealthcareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "GSL Healthcare [Member]" } } }, "localname": "GSLHealthcareMember", "nsuri": "http://agentix.com/20211130", "presentation": [ "http://agentix.com/role/OrganizationAndBasisOfPresentationDetailsNarrative" ], "xbrltype": "domainItemType" }, "agtx_GraysPeakMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Grays Peak [Member]" } } }, "localname": "GraysPeakMember", "nsuri": "http://agentix.com/20211130", "presentation": [ "http://agentix.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "agtx_InterestIncome": { "auth_ref": [], "calculation": { "http://agentix.com/role/UnauditedConsolidatedStatementOfOperations": { "order": 7.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest income earned from interest bearing assets classified as other.", "label": "Interest income" } } }, "localname": "InterestIncome", "nsuri": "http://agentix.com/20211130", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "agtx_OwnedEntityPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Owned entity Percentage" } } }, "localname": "OwnedEntityPercentage", "nsuri": "http://agentix.com/20211130", "presentation": [ "http://agentix.com/role/OrganizationAndBasisOfPresentationDetailsNarrative" ], "xbrltype": "percentItemType" }, "agtx_SBSManagementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "S B S Management [Member]" } } }, "localname": "SBSManagementMember", "nsuri": "http://agentix.com/20211130", "presentation": [ "http://agentix.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "agtx_ShareholderMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shareholder [Member]" } } }, "localname": "ShareholderMember", "nsuri": "http://agentix.com/20211130", "presentation": [ "http://agentix.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "agtx_SharesReservedForFutureIssuanceAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stated value of common units of ownership issued by a limited liability company (LLC).", "label": "Shares reserved for future issuance, amount" } } }, "localname": "SharesReservedForFutureIssuanceAmount", "nsuri": "http://agentix.com/20211130", "presentation": [ "http://agentix.com/role/EquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agentix.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agentix.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agentix.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agentix.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agentix.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agentix.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r157" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agentix.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r158" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agentix.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agentix.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line 1" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agentix.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address Address Line 2" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agentix.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agentix.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agentix.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agentix.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r159" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agentix.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agentix.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agentix.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r159" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agentix.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r161" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agentix.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agentix.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r159" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agentix.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agentix.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r160" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agentix.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r159" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agentix.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r159" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agentix.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r159" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agentix.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r159" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agentix.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agentix.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r78" ], "lang": { "en-us": { "role": { "label": "CEO [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://agentix.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r104", "r105", "r106", "r107", "r155" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://agentix.com/role/OrganizationAndBasisOfPresentationDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r104", "r105", "r106", "r107" ], "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://agentix.com/role/OrganizationAndBasisOfPresentationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Significant and Critical Accounting Policies and Practices" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r22" ], "calculation": { "http://agentix.com/role/ConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableOtherCurrent": { "auth_ref": [ "r7", "r22" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Accounts payable - other related party" } } }, "localname": "AccountsPayableOtherCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableRelatedPartiesCurrent": { "auth_ref": [ "r22", "r48", "r119", "r120" ], "calculation": { "http://agentix.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable - related party" } } }, "localname": "AccountsPayableRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r24" ], "calculation": { "http://agentix.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedRentCurrent": { "auth_ref": [ "r6", "r7", "r24" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for contractual rent under lease arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Rent expense" } } }, "localname": "AccruedRentCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r16", "r96" ], "calculation": { "http://agentix.com/role/ConsolidatedBalanceSheets": { "order": 11.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r50", "r51", "r52", "r93", "r94", "r95" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfChangesInStockholdersDeficitEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_Assets": { "auth_ref": [ "r45", "r70", "r72", "r76", "r80", "r104", "r106", "r108", "r138", "r142" ], "calculation": { "http://agentix.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "[Assets]", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r4", "r5", "r31", "r45", "r80", "r104", "r106", "r108" ], "calculation": { "http://agentix.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "[Assets, Current]", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/SignificantAndCriticalAccountingPoliciesAndPracticesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r1", "r49", "r68" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Note 1 - Organization and Basis of Presentation" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/OrganizationAndBasisOfPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r21", "r41" ], "calculation": { "http://agentix.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "periodEndLabel": "Cash - end of reporting period", "periodStartLabel": "Cash - beginning of reporting period" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/ConsolidatedBalanceSheets", "http://agentix.com/role/UnauditedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.", "label": "Net Change in Cash" } } }, "localname": "CashAndCashEquivalentsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r26", "r85", "r140", "r145" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common stock to be issued", "verboseLabel": "Common stock to be issued" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/ConsolidatedBalanceSheetsParenthetical", "http://agentix.com/role/EquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r50", "r51" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common stock par value $0.001 [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfChangesInStockholdersDeficitEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, shares par value", "verboseLabel": "Common stock, shares par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/ConsolidatedBalanceSheetsParenthetical", "http://agentix.com/role/EquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized", "verboseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/ConsolidatedBalanceSheetsParenthetical", "http://agentix.com/role/EquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued", "verboseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/ConsolidatedBalanceSheetsParenthetical", "http://agentix.com/role/EquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r15", "r86" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding", "terseLabel": "Common stock, shares outstanding", "verboseLabel": "Outstanding common stock" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/ConsolidatedBalanceSheetsParenthetical", "http://agentix.com/role/EquityDetailsNarrative", "http://agentix.com/role/OrganizationAndBasisOfPresentationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r15" ], "calculation": { "http://agentix.com/role/ConsolidatedBalanceSheets": { "order": 13.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock par value $0.001: 50,000,000 shares authorized; 35,074,605 and 34,874,605 shares issued and outstanding as of November 30, 2021 and August 31, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonUnitIssuanceValue": { "auth_ref": [], "calculation": { "http://agentix.com/role/ConsolidatedBalanceSheets": { "order": 12.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stated value of common units of ownership issued by a limited liability company (LLC).", "label": "Common stock to be issued (320,000 and 520,000 shares at November 30, 2021 and August 31, 2021, respectively)" } } }, "localname": "CommonUnitIssuanceValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationRelatedCostsPolicyTextBlock": { "auth_ref": [ "r42", "r91" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.", "label": "Compensation Related Costs, Policy [Policy Text Block]", "verboseLabel": "Related Parties" } } }, "localname": "CompensationRelatedCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/SignificantAndCriticalAccountingPoliciesAndPracticesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r63" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "- Basic and diluted" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAndDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loss per share" } } }, "localname": "EarningsPerShareBasicAndDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r43", "r64", "r65" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/SignificantAndCriticalAccountingPoliciesAndPracticesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r50", "r51", "r52", "r54", "r59", "r61", "r67", "r81", "r86", "r87", "r93", "r94", "r95", "r99", "r100", "r109", "r110", "r111", "r112", "r113", "r114", "r148", "r149", "r150" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfChangesInStockholdersDeficitEquity" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value of Financial Instruments" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/SignificantAndCriticalAccountingPoliciesAndPracticesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r35" ], "calculation": { "http://agentix.com/role/UnauditedConsolidatedStatementOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "auth_ref": [ "r47", "r102" ], "calculation": { "http://agentix.com/role/UnauditedConsolidatedStatementOfOperations": { "order": 9.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.", "label": "[Income (Loss) from Continuing Operations before Income Taxes, Domestic]", "totalLabel": "Loss before Income tax provision" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unaudited Consolidated Statement of Operations" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r46", "r60", "r61", "r69", "r98", "r101", "r103", "r147" ], "calculation": { "http://agentix.com/role/UnauditedConsolidatedStatementOfOperations": { "order": 8.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income tax provision" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r39" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Accounts payable and accounts payable - related party" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r3", "r29" ], "calculation": { "http://agentix.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r8", "r30", "r43", "r66", "r82", "r83", "r84" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventories" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/SignificantAndCriticalAccountingPoliciesAndPracticesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r23", "r45", "r73", "r80", "r105", "r106", "r107", "r108" ], "calculation": { "http://agentix.com/role/ConsolidatedBalanceSheets": { "order": 14.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "[Liabilities]", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r20", "r45", "r80", "r108", "r139", "r144" ], "calculation": { "http://agentix.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "[Liabilities and Equity]", "totalLabel": "Total liabilities and stockholders' deficit" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Stockholders' (Deficit) Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r25", "r45", "r80", "r105", "r106", "r107", "r108" ], "calculation": { "http://agentix.com/role/ConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "[Liabilities, Current]", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r9", "r10", "r11", "r12", "r13", "r45", "r80", "r105", "r106", "r107", "r108" ], "calculation": { "http://agentix.com/role/ConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Long Term Liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Parties (Details Narrative)" } } }, "localname": "LineOfCreditFacilityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_ManagementFeeExpense": { "auth_ref": [ "r119" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses related to the managing member or general partner for management of the day-to-day business functions of the limited liability company (LLC) or limited partnership (LP).", "label": "Management fees" } } }, "localname": "ManagementFeeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r37" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Cash Flows from Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r37" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Cash Flows from Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r37", "r38", "r40" ], "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Used in Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows from Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r0", "r32", "r33", "r34", "r40", "r45", "r53", "r55", "r56", "r57", "r58", "r60", "r61", "r62", "r70", "r71", "r74", "r75", "r77", "r80", "r108", "r141", "r146" ], "calculation": { "http://agentix.com/role/UnauditedConsolidatedStatementOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "[Net Income (Loss) Attributable to Parent]", "terseLabel": "Net loss", "totalLabel": "Net loss", "verboseLabel": "Net Loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfCashFlows", "http://agentix.com/role/UnauditedConsolidatedStatementOfChangesInStockholdersDeficitEquity", "http://agentix.com/role/UnauditedConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/SignificantAndCriticalAccountingPoliciesAndPracticesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://agentix.com/role/UnauditedConsolidatedStatementOfOperations": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "[Operating Expenses]", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r70", "r71", "r74", "r75", "r77" ], "calculation": { "http://agentix.com/role/UnauditedConsolidatedStatementOfOperations": { "order": 6.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "[Operating Income (Loss)]", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization and Basis of Presentation" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherIncomeAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other (Income)" } } }, "localname": "OtherIncomeAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_PaymentsForAdvanceToAffiliate": { "auth_ref": [ "r36" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow from advancing money to an affiliate (an entity that is related but not strictly controlled by the entity).", "label": "Advances" } } }, "localname": "PaymentsForAdvanceToAffiliate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfessionalFees": { "auth_ref": [ "r153", "r154" ], "calculation": { "http://agentix.com/role/UnauditedConsolidatedStatementOfOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.", "label": "Professional fees", "verboseLabel": "Consulting fees" } } }, "localname": "ProfessionalFees", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/RelatedPartiesDetailsNarrative", "http://agentix.com/role/UnauditedConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r89", "r117", "r118" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r89", "r117", "r118", "r120" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r89" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party." } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Parties" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r89", "r117", "r120", "r126", "r127", "r128", "r129", "r130", "r131", "r132", "r133", "r134", "r135", "r136", "r137" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r115", "r116", "r118", "r121", "r122" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Note 3 - Related Parties" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/RelatedParties" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r97", "r156" ], "calculation": { "http://agentix.com/role/UnauditedConsolidatedStatementOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r43", "r97" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Developments" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/SignificantAndCriticalAccountingPoliciesAndPracticesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r17", "r87", "r96", "r143", "r151", "r152" ], "calculation": { "http://agentix.com/role/ConsolidatedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r50", "r51", "r52", "r54", "r59", "r61", "r81", "r93", "r94", "r95", "r99", "r100", "r148", "r150" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated Deficit [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfChangesInStockholdersDeficitEquity" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Common Stock Sold" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/OrganizationAndBasisOfPresentationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction.", "label": "Percentage of Shares issued" } } }, "localname": "SaleOfStockPercentageOfOwnershipAfterTransaction", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/OrganizationAndBasisOfPresentationDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r43", "r90", "r92" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Stock-Based Payments" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/SignificantAndCriticalAccountingPoliciesAndPracticesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/EquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r86" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "[Shares, Issued]", "periodEndLabel": "Balance, shares", "periodStartLabel": "Balance, shares" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfChangesInStockholdersDeficitEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r49" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Note 2 - Significant and Critical Accounting Policies and Practices" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/SignificantAndCriticalAccountingPoliciesAndPractices" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r28", "r50", "r51", "r52", "r54", "r59", "r61", "r67", "r81", "r86", "r87", "r93", "r94", "r95", "r99", "r100", "r109", "r110", "r111", "r112", "r113", "r114", "r148", "r149", "r150" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfChangesInStockholdersDeficitEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/OrganizationAndBasisOfPresentationDetailsNarrative", "http://agentix.com/role/RelatedPartiesDetailsNarrative", "http://agentix.com/role/UnauditedConsolidatedStatementOfChangesInStockholdersDeficitEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unaudited Consolidated Statement of Cash Flows" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidated Balance Sheets" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unaudited Consolidated Statement of Changes in Stockholders (Deficit) Equity" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r50", "r51", "r52", "r67", "r125" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/OrganizationAndBasisOfPresentationDetailsNarrative", "http://agentix.com/role/RelatedPartiesDetailsNarrative", "http://agentix.com/role/UnauditedConsolidatedStatementOfChangesInStockholdersDeficitEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Common stock share issued for service, shares" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/EquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r14", "r15", "r86", "r87" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Issuance of previous common stock to be issue, shares" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfChangesInStockholdersDeficitEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r14", "r15", "r86", "r87" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Issuance of previous common stock to be issue, amount" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfChangesInStockholdersDeficitEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r15", "r18", "r19", "r45", "r79", "r80", "r108" ], "calculation": { "http://agentix.com/role/ConsolidatedBalanceSheets": { "order": 15.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "[Stockholders' Equity Attributable to Parent]", "periodEndLabel": "Balance, amount", "periodStartLabel": "Balance, amount", "totalLabel": "Total stockholders' deficit" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/ConsolidatedBalanceSheets", "http://agentix.com/role/UnauditedConsolidatedStatementOfChangesInStockholdersDeficitEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Deficit", "verboseLabel": "Stockholders' Deficit" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/ConsolidatedBalanceSheets", "http://agentix.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r44", "r87", "r88" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Note 4 - Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/Equity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r123", "r124" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Note 5 - Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Weighted average common shares outstanding- Basic and diluted" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average common shares outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agentix.com/role/UnauditedConsolidatedStatementOfOperations" ], "xbrltype": "stringItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r1": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r122": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r124": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(k)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262090&loc=SL114874205-224268" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r157": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r158": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r159": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r161": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18726-107790" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(1)(i))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r49": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r68": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314" }, "r84": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r88": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f(1))", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" } }, "version": "2.1" } ZIP 33 0001477932-22-000229-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001477932-22-000229-xbrl.zip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`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